Compositions having capsules with double shells and nanoparticle layers

By using microencapsulation technology with an inorganic double-shell structure, the challenges of stability and release control of active substances in existing technologies have been solved, achieving consistent permeability and mechanical integrity under mechanical stress, making it suitable for hair care and personal care products.

CN119012995APending Publication Date: 2024-11-22PROCTER & GAMBLE CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380033202.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-12
Filing Date
2023-04-11
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing microencapsulation technologies face challenges in maintaining the stability of active substances and controlling release, especially in achieving accurate rupture time under mechanical stress. Furthermore, traditional polymer capsules cannot simultaneously satisfy the balance between low shell permeability, mechanical properties, and rupture characteristics.

Method used

A double-shell structure containing inorganic materials is adopted. The first shell component consists of a condensation layer and a nanoparticle layer, and the second shell component surrounds the nanoparticle layer. By selecting appropriate precursor compounds and proportions to prepare capsules, better mechanical integrity and permeability control are achieved.

Benefits of technology

It achieves stable storage and consistent release of active ingredients, ensures the preservation of the intended properties of fragrance during use and storage, provides improved mechanical properties and low permeability, and is suitable for hair care and personal care products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119012995A_ABST
    Figure CN119012995A_ABST
Patent Text Reader

Abstract

A composition having one or more leak-proof capsules.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates to compositions comprising capsules for triggered release of beneficial agents. Background Art

[0002] Microencapsulation is a process in which liquid droplets, solid particles or gases are encapsulated in a solid shell and are generally within a micro-size range. The core material is then mechanically separated from the surrounding environment (Jyothi et al., Journal of Microencapsulation, 2010, 27, 187-197). Microencapsulation technology is receiving attention from various scientific fields and has a wide range of commercial applications in different industries. In general, capsules can achieve one or more of the following: (i) providing the stability of a preparation or material by mechanically separating incompatible components, (ii) protecting the core material from the influence of the surrounding environment, (iii) masking or hiding the undesirable properties of the active ingredient, and (iv) controlling or triggering the release of the active ingredient to a specific time or position. All of these attributes can extend the shelf life of several products and stabilize the active ingredient in the liquid preparation.

[0003] Encapsulation can be found in fields such as medicine, personal care, textiles, food, coatings and agriculture. In addition, in practical commercial applications, the main challenge faced by microencapsulation technology is that the active substance encapsulated in the capsule needs to be completely retained in the capsule throughout the supply chain until the controlled or triggered release of the core material is applied (Thompson et al., Journal of Colloid and Interface Science, 2015, 447, 217-228). There are significantly limited microencapsulation technologies, which are safe for the environment and human health, have long-term retention and active protection capabilities, and can meet the needs of today's industry, especially when it involves encapsulation of small molecules.

[0004] In the past few years, consumer product manufacturers have used core-shell encapsulation technology to preserve active substances such as beneficial agents in harsh environments and release them at a desired time, which can be during or after the use of the consumer product. Among the several mechanisms that can be used to release beneficial agents, the mechanism that is usually relied on is mechanical rupture of the capsule shell. Selecting mechanical rupture as a release mechanism poses another challenge to manufacturers because the rupture must occur at a specific desired time, even if the capsule is mechanically stressed before the desired release time.

[0005] Industrial interest in encapsulation technology has led to the development of several polymer capsule chemistries that attempt to meet the requirements of low shell permeability, high deposition, targeted mechanical properties and rupture characteristics. Increased environmental concerns have brought polymer capsules under scrutiny, so manufacturers have begun to investigate sustainable solutions for encapsulating beneficial agents. There is a large amount of literature on sustainable capsules based on metal oxides or semi-metal oxides, primarily silica capsules; however, none of the capsules described in the literature provide the correct balance of low shell permeability, mechanical properties, deposition and rupture characteristics.

[0006] Capsules made with only silane monomers are known in the art. Multiple patent applications and academic publications disclose the use of monomers such as tetramethoxysilane (TMOS) and tetraethoxysilane (TEOS). The advantage of using such monomers is that they react faster than prepolymers made from similar monomers and have therefore been a preferred choice for many years. This rapid reaction time is due to their higher water solubility after partial hydrolysis compared to larger precursors due to the lower molecular weight of the former, which further accelerates the overall hydrolysis kinetics since they are in excess water after being dispersed in the phase. However, these types of disclosures typically use cationic surfactants, such as cetyltrimethylammonium chloride (CTAC) or cetyltrimethylammonium bromide (CTAB), which are presumably used to push the negatively charged hydrolysis intermediate reaction species dispersed in the aqueous phase toward the oil / water interface.

[0007] Without being bound by theory, it is generally the case that partially hydrolyzed monomers in excess water begin to condense and form larger particle sols that are attracted to the oil / water interface. Ultimately, the system is expected to reduce the surface energy of the dispersed particle sols by means of thermodynamic laws, which is conducive to having sols at the oil / water interface, especially when they become larger. The formation of such particle sols will eventually lead to a shell around the oil droplets, and in some cases even to a shell that is strong enough for mechanical self-integrity. However, due to the geometric characteristics of the particle sols (size, fractal dimension, shape, etc.), they cannot form a shell with a dense non-porous network, thereby providing low shell permeability.

[0008] In addition, WO 2011 / 131644 discloses capsules having a semi-metallic organic shell by bonding nanoparticles together using oil-soluble semi-metallic precursors. However, the reference does not disclose a second shell component. In the present invention, it has been found that selectively selecting nanoparticles and precursors coupled to the second shell component can provide capsules with reduced permeability and increased mechanical integrity.

[0009] Without wishing to be bound by theory, applicants have surprisingly discovered that careful selection of primary shell components, secondary shell components, nanoparticles, core-shell ratio, and shell thickness allows for the preparation of metal oxide or semi-metal oxide based capsules that, in combination with certain compositions, impart improved performance characteristics to those compositions. Summary of the invention

[0010] Provided is a hair care composition comprising: a surfactant; at least one of a fatty alcohol, a cationic polymer or a mixture thereof; one or more capsules; a capsule comprising a core and a shell surrounding the core; wherein the core comprises a perfume raw material; wherein the shell comprises a substantially inorganic first shell component, the first shell component comprising a condensation layer and a nanoparticle layer; wherein the condensation layer comprises a condensation product of a precursor; wherein the nanoparticle layer comprises inorganic nanoparticles; and wherein the condensation layer is disposed between the core and the nanoparticle layer; an inorganic second shell component surrounding the first shell component, wherein the second shell component surrounds the nanoparticle layer;

[0011] wherein the precursor comprises at least one compound of formula (I), formula (II) or a mixture thereof,

[0012] Wherein formula (I) is (MvOzYn)w,

[0013] Wherein the formula (II) is (MvOzYnR1p)w,

[0014] Wherein for formula (I), formula (II) or a mixture thereof:

[0015] Each M is independently selected from silicon, titanium and aluminum,

[0016] v is the valence number of M and is 3 or 4,

[0017] z is 0.5 to 1.6,

[0018] Each Y is independently selected from -OH, -OR 2 ,halogen, -NH2,-

[0019] NHR 2 、-N(R 2 )2 and

[0020] wherein R2 is C1 to C20 alkyl, C1 to C20 alkylene, C6 to C22 aryl or 5- to 12-membered heteroaryl, wherein the heteroaryl contains 1 to 3 ring heteroatoms selected from O, N and S,

[0021] Wherein R3 is H, C1 to C20 alkyl, C1 to C20 alkylene, C6

[0022] to C22 aryl or 5- to 12-membered heteroaryl, wherein the heteroaryl contains 1 to 3 ring heteroatoms selected from O, N and S,

[0023] w is 2 to 2000;

[0024] Wherein for formula (I),

[0025] n is 0.7 to (v-1); and

[0026] Wherein for formula (II),

[0027] n is 0 to (v-1);

[0028] Each R1 is independently selected from: C1 to C30 alkyl; C1 to C30 alkylene; C1 to C30 alkyl substituted by a member selected from: halogen, -

[0029] OCF3, -NO2, -CN, -NC, -OH, -OCN, -NCO, alkoxy, epoxy, amino, mercapto, acryloyl, -CO2H, -C(O)-alkyl, -

[0030] C(O)O-aryl and -C(O)O-heteroaryl; and C1 to C30 alkylene substituted by a member selected from halogen, -OCF3, -NO2, -CN, -NC,

[0031] -OH, -OCN, -NCO, alkoxy, epoxy, amino, mercapto, acryloyl, -C(O)OH, -C(O)O-alkyl, -C(O)O-aryl, and -C(O)O-heteroaryl; and

[0032] p is a number greater than zero and at most pmax,

[0033] Where pmax = 60 / [9*Mw(R1)+8],

[0034] Where Mw(R1) is the molecular weight of the R1 group.

[0035] Provided is a personal care composition comprising: a surfactant; a skin conditioning agent, and one or more capsules; a capsule comprising a core and a shell surrounding the core; wherein the core comprises a fragrance raw material; wherein the shell comprises a substantially inorganic first shell component, the first shell component comprising a condensation layer and a nanoparticle layer; wherein the condensation layer comprises a condensation product of a precursor; wherein the nanoparticle layer comprises inorganic nanoparticles; and wherein the condensation layer is disposed between the core and the nanoparticle layer; an inorganic second shell component surrounding the first shell component, wherein the second shell component surrounds the nanoparticle layer;

[0036] The precursor comprises at least one compound of formula (I), formula (II) or a mixture thereof, wherein formula (I) is (MvOzYn)w,

[0037] Wherein the formula (II) is (MvOzYnR1p)w,

[0038] Wherein for formula (I), formula (II) or a mixture thereof:

[0039] Each M is independently selected from silicon, titanium and aluminum,

[0040] v is the valence number of M and is 3 or 4,

[0041] z is 0.5 to 1.6,

[0042] Each Y is independently selected from -OH, -OR 2 ,halogen, -NH2,-

[0043] NHR 2 、-N(R 2 )2 and

[0044] wherein R2 is C1 to C20 alkyl, C1 to C20 alkylene, C6 to C22 aryl or 5- to 12-membered heteroaryl, wherein the heteroaryl contains 1 to 3 ring heteroatoms selected from O, N and S,

[0045] wherein R3 is H, C1 to C20 alkyl, C1 to C20 alkylene, C6 to C22 aryl or 5- to 12-membered heteroaryl, wherein the heteroaryl contains 1 to 3 ring heteroatoms selected from O, N and S,

[0046] w is 2 to 2000;

[0047] Wherein for formula (I),

[0048] n is 0.7 to (v-1); and

[0049] Wherein for formula (II),

[0050] n is 0 to (v-1);

[0051] each R1 is independently selected from: C1 to C30 alkyl; C1 to C30 alkylene; C1 to C30 alkyl substituted by a member selected from the group consisting of halogen, -OCF3, -NO2, -CN, -NC, -OH, -OCN, -NCO, alkoxy, epoxy, amino, mercapto, acryl, -CO2H, -C(O)-alkyl, -C(O)O-aryl, and -C(O)O-heteroaryl; and C1 to C30 alkylene substituted by a member selected from the group consisting of halogen, -OCF3, -NO2, -CN, -NC, -OH, -OCN, -NCO, alkoxy, epoxy, amino, mercapto, acryl, -C(O)OH, -C(O)O-alkyl, -C(O)O-aryl, and -C(O)O-heteroaryl; and

[0052] p is a number greater than zero and at most pmax,

[0053] Where pmax = 60 / [9*Mw(R1)+8],

[0054] Where Mw(R1) is the molecular weight of the R1 group. BRIEF DESCRIPTION OF THE DRAWINGS

[0055] Although the specification ends with claims that specifically point out and clearly claim what is considered to be the subject matter of the present disclosure, it is believed that the present disclosure can be more fully understood from the following description in conjunction with the accompanying drawings. Some of these figures may have been simplified by omitting selected elements in order to more clearly show other elements. Such omissions of elements in certain figures do not necessarily indicate the presence or absence of a particular element in any exemplary embodiment unless such is clearly described in the corresponding text description. The drawings are not drawn to scale.

[0056] Figure 1 A schematic diagram of a method for preparing a capsule having a first shell component, the capsule being prepared with a hydrophobic core is shown.

[0057] Figure 2 A schematic diagram of a capsule having a first shell part and a second shell part is shown.

[0058] Figure 3 Scanning electron microscope image of the capsule.

[0059] Figure 4 is a graph of the leakage results for the capsules of the present invention and the comparative capsules in Hair Care Composition 1, as detailed in Table 7.

[0060] Figure 5 is a graph of the leakage results for the capsules of the present invention and the comparative capsules in Hair Care Composition 2, as detailed in Table 7.

[0061] Figure 6is a graph showing the leakage results of the capsules of the present invention and the comparative capsules in the hair care composition 3, as detailed in Table 8 DETAILED DESCRIPTION

[0062] The present disclosure relates to liquid hair care, personal care and shave care compositions comprising a population of capsules with a fragrance raw material. The shell of the capsules contains an inorganic material, the selection of which results in improved mechanical properties and low and / or consistent permeability.

[0063] It has been found that the capsules present in the disclosed inventive compositions work surprisingly well in controlling the leakage of fragrance raw materials, resulting in relatively low and consistent fragrance leakage. Without being bound by theory, it is believed that a completely different mechanism of a shell containing a highly cross-linked inorganic material drives the leakage of fragrance raw materials compared to a shell containing an organic polymer material. Specifically, the diffusion of small molecules such as fragrance raw materials ("PRMs") through a homogeneous organic polymer shell is similar to the diffusion mechanism through a homogeneous polymer membrane. In this case, the permeability of the polymer membrane to a given solute depends on the polymer free volume (affected by crystallinity and cross-link density) and the relative solubility of the solute to the polymer. Since different PRMs will have different ranges of relevant physical and chemical properties (e.g., molecular weight and polarity), when the physical and chemical properties are also uniform, the diffusion rate is not uniform for a given group of PRMs.

[0064] On the other hand, it is believed that the diffusion of small molecules through the highly cross-linked inorganic shell occurs mainly through the microchannels formed by the percolation network of micropores present in the shell. As disclosed in the present disclosure, this highly cross-linked inorganic shell can be obtained by using a combination of a second shell component and a first shell component. In this case, it is believed that the permeability of the inorganic shell depends mainly on the number, density and size of the microchannels that effectively connect the core and the continuous phase, which can cause the PRM leakage rate to be relatively uniform or consistent with each other, and relatively low. Because various PRMs leak from the disclosed capsules in the disclosed composition at a relatively consistent rate, it is further believed that the expected properties of the fragrance during use and storage of the hair care, personal care and shaving care compositions of the present invention are maintained, thereby producing more satisfactory and consistent olfactory performance.

[0065] Skin Conditioners

[0066] The compositions of the present invention may contain one or more skin conditioning agents.

[0067] The one or more skin conditioning agents may contain one or more silicone conditioning agents. Examples of silicones include polydimethylsiloxane, polydimethylsiloxane alcohol, cyclic siloxane, methylphenyl polysiloxane and modified silicones with various functional groups, such as amino groups, quaternary ammonium salt groups, aliphatic groups, alcohol groups, carboxylic acid groups, ether groups, sugar or polysaccharide groups, fluorine-modified alkyl groups, alkoxy groups or combinations of such groups. Such silicones may be soluble or insoluble in aqueous (or non-aqueous) product carriers. In the case of insoluble liquid silicones, silicones may be in an emulsified form with a droplet size of about 10 nm to about 30 microns. Other solid or semi-solid conditioning agents may be present in the composition, including high melting temperature fatty alcohols, acids, esters, amides or oligomers formed by unsaturated esters, alcohols, amides. Low esters may be the result of oligomerization of naturally occurring unsaturated glycerides. Such solid or semi-solid conditioning agents may be added or present as a mixture with an organic oil.

[0068] The one or more skin conditioning agents may also include at least one organic conditioning material (such as an oil or wax) alone or in combination with other conditioning agents (such as the above-mentioned silicone conditioning agents). The organic material may be non-polymeric, oligomeric or polymeric. It may be in the form of an oil or wax and may be added in a pure formulation or in a pre-emulsified form. Some non-limiting examples of organic conditioning materials include, but are not limited to: i) hydrocarbon oils; ii) polyolefins; iii) fatty esters; iv) fluorinated conditioning compounds; v) fatty alcohols; vi) alkyl glucosides and alkyl glucoside derivatives; vii) quaternary ammonium compounds; viii) polyethylene glycols and polypropylene glycols having a molecular weight of up to about 2,000,000, including those having the CTFA designations PEG-200, PEG-400, PEG-600, PEG-1000, PEG-2M, PEG-7M, PEG-14M, PEG-45M, and mixtures thereof.

[0069] The one or more skin conditioning agents may also include a conditioning agent that is at least one of a humectant or a moisturizer, each of which may be present at a level of from about 0.01% to about 40%, more preferably from about 0.1% to about 30%, and even more preferably from about 0.5% to about 15%, by weight of the composition. These materials include, but are not limited to, guanidine; urea; glycolic acid and glycolate salts (e.g., ammonium and quaternary alkyl ammonium); lactic acid and lactate salts (e.g., ammonium and quaternary alkyl ammonium); aloe vera in any of a variety of forms (e.g., aloe vera gel); polyols such as sorbitol, mannitol, glycerol, hexanetriol, butanetriol, propylene glycol, butylene glycol, hexylene glycol, etc.; polyethylene glycol; sugars (e.g., melibiose) and starches; sugar and starch derivatives (e.g., alkoxylated glucose, fructose, sucrose, etc.); hyaluronic acid; lactamide monoethanolamine; acetamide monoethanolamine; sucrose polyesters; petrolatum; and mixtures thereof.

[0070] Suitable moisturizers (also referred to herein as humectants) include urea, guanidine, glycolic acid and glycolate salts (e.g., ammonium and quaternary alkyl ammonium), lactic acid and lactate salts (e.g., ammonium and quaternary alkyl ammonium), aloe vera in any of its various forms (e.g., aloe vera gel), polyhydroxy alcohols (such as sorbitol, glycerol, hexanetriol, propylene glycol, hexylene glycol, etc.), polyethylene glycols, sugars and starches, sugar and starch derivatives (e.g., alkoxylated glucoses), hyaluronic acid, lactamide monoethanolamine, acetamide monoethanolamine, and mixtures thereof.

[0071] The one or more skin conditioning agents may also include a benefit agent, which may be a liquid benefit agent. A liquid benefit agent is considered to be a liquid if it is in its natural state at room temperature (i.e., 23° C.). The liquid benefit agent may have a viscosity of less than about 1000 cP, less than about 800 cP, or less than about 600 cP, and may be measured with a standard rheometer.

[0072] The liquid benefit agent may have a hydrophobic component. The hydrophobic component may be, for example, a water-dispersible non-volatile liquid. The water-dispersible non-volatile liquid benefit agent may have a Vaughn solubility parameter (VSP) ranging from about 5 to about 14. Non-limiting examples of hydrophobic benefit materials having a VSP value ranging from about 5 to about 14 include the following: cyclomethicone (5.9), squalene (6.0), isopropyl palmitate (7.8), isopropyl myristate (8.0), castor oil (8.9), cholesterol (9.6), butylene glycol (13.2), soybean oil, olive oil (7.87), mineral oil (7.1), and combinations thereof.

[0073] Non-limiting examples of glycerolipids suitable for use as liquid benefit agents herein can include castor oil, safflower oil, corn oil, walnut oil, peanut oil, olive oil, cod liver oil, almond oil, avocado oil, palm oil, sesame oil, soybean oil, vegetable oil, sunflower seed oil, coconut oil, cottonseed oil, jojoba oil, and combinations thereof.

[0074] Non-limiting examples of glyceride derivatives suitable for use as liquid benefit agents herein may include cationic derivatives, amino acid derivatives, alkanolamide derivatives, esterified derivatives, ether derivatives, hydrogenated derivatives, and combinations thereof.

[0075] Non-limiting examples of metathesis oligomers suitable for use as liquid benefit agents herein may include, for example, oligomers derived from the metathesis of unsaturated polyol esters. Exemplary metathesis unsaturated polyol esters and their starting materials are listed in U.S. Patent Application US2009 / 0220443A1, which is incorporated herein by reference. Unsaturated polyol esters are unsaturated glycerides. The source of unsaturated glycerol polyol esters includes synthetic oils, vegetable oils, algae oils, bacteria-derived oils and animal oils, combinations of these, etc. Representative examples of vegetable oils include argan oil, canola oil, rapeseed oil, coconut oil, corn oil, cottonseed oil, olive oil, palm oil, peanut oil, safflower oil, sesame oil, soybean oil, sunflower oil, high oleyl soybean oil, high oleyl sunflower oil, linseed oil, palm kernel oil, tung oil, castor oil, high erucic rapeseed oil, jatropha oil, combinations of these, etc. Representative examples of animal oils include fish oils, etc. Representative examples of synthetic oils include tall oil, which is a by-product of wood pulp production.

[0076] Other examples of unsaturated polyol esters include diesters (such as those derived from ethylene glycol or propylene glycol), esters (such as those derived from pentaerythritol or dipentaerythritol), or sugar esters (such as ). Non-limiting examples of suitable sucrose polyesters include 1618S, 1618U, 1618S B6, 1618U B6, Sefa Cottonate, Sefa C895, Sefa C1095, 1618S B4.5, all available from The Procter and Gamble Co., Cincinnati, Ohio. Other examples of suitable natural polyol esters may include, but are not limited to, sorbitol esters, maltitol esters, sorbitan esters, maltodextrin derived esters, xylitol esters, and other sugar derived esters. The polyol ester oligomers may also be further modified by partial hydroformylation of the unsaturated functionality to provide one or more OH groups and increase the hydrophilicity of the oligomer.

[0077] Non-limiting examples of hydrocarbons suitable for use as liquid benefit agents herein may include carbon chain lengths of about C6 or higher, including alkanes, polyalkanes, olefins, polyolefins, and combinations thereof. Non-limiting examples include mineral oils.

[0078] Non-limiting examples of glyceride derivatives useful as liquid benefit agents herein may include cationic derivatives, amino acid derivatives, alkanolamide derivatives, esterified derivatives, ether derivatives, hydrogenated or partially hydrogenated oils and derivatives thereof, and combinations thereof.

[0079] Non-limiting examples of alkyl esters suitable for use as liquid benefit agents herein may include isopropyl esters of fatty acids and long chain esters of long chain (ie, C10-C16) fatty acids, non-limiting examples of which may include isopropyl palmitate, isohexyl palmitate, and isopropyl myristate.

[0080] Non-limiting examples of silicone oils suitable for use as hydrophobic liquid skin benefit agents herein may include dimethicone copolyols, dimethylpolysiloxane, diethylpolysiloxane, mixed C1-C30 alkyl polysiloxanes, phenyl dimethicone, dimethiconol, and combinations thereof. Non-limiting examples of silicone oils useful herein are described in U.S. Pat. No. 5,011,681. Other suitable hydrophobic skin benefit agents may also include milk triglycerides (such as hydroxylated milk glycerides) and polyol fatty acid polyesters.

[0081] The benefit agent may also be non-liquid. Some examples of non-liquid benefit agents include hydrocarbons. Non-limiting examples of hydrocarbons suitable for use as non-liquid benefit agents herein may include petrolatum, microcrystalline wax, polyalkanes, polyolefins, and combinations thereof.

[0082] Non-limiting examples of glycerides suitable for use as non-liquid benefit agents herein can include vegetable waxes, animal fats, hydrogenated or partially hydrogenated vegetable oils such as shea butter, hydrogenated soybean oil, hydrogenated palm, lanolin, lard, and combinations thereof.

[0083] Non-limiting examples of metathesized glycerides suitable for use as non-liquid benefit agents herein can include metathesized palm oil, hydrogenated or partially hydrogenated metathesized soybean oil, and canola oil, and combinations thereof.

[0084] Non-limiting examples of alkyl esters suitable for use as non-liquid benefit agents herein may include isopropyl esters of fatty acids and long chain esters of long chain (i.e., C10-C24) fatty acids such as cetyl ricinoleate, non-limiting examples of which may include cetyl ricinoleate and octadecyl ricinoleate. Other examples may include hexyl laurate, isohexyl laurate, myristyl myristate, decyl oleate, isodecyl oleate, hexadecyl stearate, decyl stearate, isopropyl isostearate, diisopropyl adipate, diisohexyl adipate, dihexyldecyl adipate, diisopropyl sebacate, acyl isononanoate lauryl lactate, myristyl lactate, cetyl lactate, and combinations thereof.

[0085] Non-limiting examples of alkenyl esters suitable for use as non-liquid benefit agents can include oleyl myristate, oleyl stearate, oleyl oleate, and combinations thereof.

[0086] Non-limiting examples of polyglycerol fatty acid esters suitable for use as non-liquid benefit agents herein can include decaglyceryl distearate, decaglyceryl diisostearate, decaglyceryl monomyristate, decaglyceryl monolaurate, hexaglyceryl monooleate, and combinations thereof.

[0087] Non-limiting examples of lanolin and lanolin derivatives suitable for use as non-liquid benefit agents herein can include lanolin, lanolin wax, lanolin alcohol, lanolin fatty acid, isopropyl lanolate, acetylated lanolin, acetylated lanolin alcohol, lanolin linoleate, lanolin ricinoleate, and combinations thereof.

[0088] Non-limiting examples of silicones suitable for use as hydrophobic liquid skin benefit agents can include silicone elastomers.

[0089] Other suitable benefit agents are described in US Patent Application Publication No. 2012 / 0009285.

[0090] The benefit phase may also include a crystalline hydrophobic ethylene copolymer. The ethylene copolymer is a random copolymer and may be present from about 0.01% to about 5% by weight of the personal care composition. The crystalline hydrophobic ethylene copolymer may be present from about 0.05% to about 2% by weight of the personal care composition. As another example, the crystalline hydrophobic ethylene copolymer may be present from about 0.1% to about 1.5% by weight of the personal care composition.

[0091] The crystalline hydrophobic ethylene copolymer contains at least 40% ethylene monomer by weight of the crystalline hydrophobic ethylene acrylate copolymer. The crystalline hydrophobic ethylene copolymer may contain ethylene monomers from about 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97% to about 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50% or any combination thereof to form a range.

[0092] In addition, the crystalline hydrophobic ethylene copolymer may include an acrylate monomer. The polymer may contain from about 1% to about 60% acrylate monomer by weight of the polymer. The acrylate monomer may be defined by the following formula: (R 1 )(R 2 )C=C(R 3 )(COOR 4 ), where each R 1 , R 2 and R 3 is independently H or C1-C4-alkyl, in one example H or methyl, in another example R 1 , R 2 and R 3 Two of them are H and the other is H or methyl, in another example R1 , R 2 and R 3 are both H; and R 4 C1-C 20 -alkyl or selected from straight chain and branched chain alkyl groups having 4 to 20, 6 to 20, 8 to 20 or 9 to 20 carbon atoms.

[0093] Some examples of suitable crystalline hydrophobic ethylene acrylate copolymers include ethylene: propylheptyl acrylate, ethylene: propylheptyl acrylate: vinyl acetate, and combinations thereof. Suitable crystalline hydrophobic ethylene acrylate copolymers may include 86.2% ethylene: 13.8% propylheptyl acrylate; 90.4% ethylene: 9.6% propylheptyl acrylate; 96% ethylene: 4% propylheptyl acrylate; or 81.8% ethylene: 9.6% propylheptyl acrylate: 8.6% vinyl acetate.

[0094] The crystalline hydrophobic ethylene copolymer may include vinyl acetate monomers. The vinyl acetate monomers may be defined by the formula: (R 10 )(R 11 )C=C(R 9 )(COR 12 ), where R 9 are independently H or C1-C4-alkyl, R 10 and R 11 One of them is -C(O)R 13 and the other is H or C1-C4-alkyl; and R 12 and R 13 Each independently is -OH or C1-C 20 -alkoxy; or R 12 and R 13 Together they form an -O- group.

[0095] In addition, the crystalline hydrophobic ethylene acrylate copolymer may include a combination of ethylene, propylheptyl acrylate, and an additional monomer. The additional monomer may be up to 10% by weight of the copolymer. The additional monomer may be represented by (R 5 )(R 6 )C=C(R 7 )(OCOR 8 ), where each R 5 , R 6 and R 7 are independently H or C1-C4-alkyl, preferably H or methyl, more preferably R 5 , R 6 and R 7 Two of them are H and the other is H or methyl, in particular R 5 , R 6 and R7 are both H; and R 8 C1-C 20 -alkyl, preferably C1-C9-alkyl, more preferably C1-C3-alkyl, especially or methyl, and especially methyl. A suitable example of such additional monomers is vinyl acetate.

[0096] Hair care composition

[0097] The capsules of the present invention can be used in hair care compositions to provide one or more benefits, including freshness, malodor removal, softness and styling. The hair care compositions of the present invention can be in different forms. Non-limiting examples of such forms are shampoos, conditioning shampoos, pet shampoos, leave-in treatments, sprays, liquids, pastes, Newtonian or non-Newtonian fluids, gels and sols.

[0098] The hair care composition may comprise a capsule having at least one benefit agent at a level that promotes one or more benefits without damaging the hair when used directly. Such benefit agents may include spices, essential oils, silicones, waxes, and mixtures thereof. Spices may comprise a single fragrance raw material or a mixture of fragrance raw materials. Examples of essential oils are argan oil, lavender oil, peppermint oil, rosemary oil, thyme oil, cedarwood oil, lemongrass oil, ylang-ylang oil, and mixtures thereof.

[0099] In an embodiment of the present invention, the hair care composition comprises from about 0.01 wt % to about 15 wt % of at least one benefit agent encapsulated in a capsule. In another embodiment, the hair care composition comprises from about 0.05 wt % to about 8 wt % of at least one encapsulated benefit agent. In another embodiment, the hair care composition comprises from about 0.1 wt % to about 5 wt % of at least one encapsulated benefit agent.

[0100] In addition to the capsules, the hair care compositions of the present invention may contain a detersive surfactant, an aqueous carrier, a shampoo gel base and other additional ingredients.

[0101] Detergent surfactant

[0102] The hair care composition may include one or more detersive surfactants that provide cleaning properties to the composition. The one or more detersive surfactants may in turn include anionic surfactants, amphoteric surfactants or zwitterionic surfactants, or mixtures thereof. Various examples and descriptions of detersive surfactants are described in U.S. Patent No. 6,649,155, U.S. Patent Application Publication No. 2008 / 0317698, and U.S. Patent Application Publication No. 2008 / 0206355, which are incorporated herein by reference in their entirety.

[0103] The concentration of the detersive surfactant component in the hair care composition should be sufficient to provide the desired cleaning and foaming performance, and generally ranges from 2 wt. % to about 50 wt. %, from about 5 wt. % to about 30 wt. %, from about 8 wt. % to about 25 wt. %, from about 10 wt. % to about 20 wt. %, about 5 wt. %, about 10 wt. %, about 12 wt. %, about 15 wt. %, about 17 wt. %, about 18 wt. % or about 20 wt. %.

[0104] Suitable anionic surfactants for use in the composition are alkyl sulfates and alkyl ether sulfates. Other suitable anionic surfactants are water-soluble salts of organic sulfuric acid reaction products. Other suitable anionic surfactants are the reaction products of fatty acids esterified with isethionates and neutralized with sodium hydroxide. Other similar anionic surfactants are described in U.S. Pat. Nos. 2,486,921, 2,486,922 and 2,396,278, which are incorporated herein by reference in their entirety.

[0105] Exemplary anionic surfactants for use in the hair care composition include ammonium lauryl sulfate, ammonium laureth sulfate, triethylamine lauryl sulfate, triethylamine laureth sulfate, triethanolamine lauryl sulfate, triethanolamine laureth sulfate, monoethanolamine lauryl sulfate, monoethanolamine laureth sulfate, diethanolamine lauryl sulfate, diethanolamine laureth sulfate, sodium lauric acid monoglyceride sulfate, sodium lauryl sulfate, laureth In another embodiment, the anionic surfactant is sodium lauryl sulfate, sodium lauryl sulfate, sodium lauryl sarcosinate, sodium lauroyl sarcosinate, lauryl sarcosine, cocoyl sarcosine, ammonium cocoyl sulfate, ammonium lauroyl sulfate, sodium cocoyl sulfate, sodium lauroyl sulfate, potassium cocoyl sulfate, potassium lauryl sulfate, triethanolamine lauryl sulfate, triethanolamine lauryl sulfate, monoethanolamine cocoyl sulfate, monoethanolamine lauryl sulfate, sodium tridecylbenzene sulfonate, sodium dodecylbenzene sulfonate, sodium cocoyl isethionate, and combinations thereof. In another embodiment, the anionic surfactant is sodium lauryl sulfate or sodium laureth sulfate.

[0106] Suitable amphoteric or zwitterionic surfactants for use in the hair care compositions herein include those known for use in shampoos or other personal care cleansing. The concentration of such amphoteric surfactants ranges from about 0.5% to about 20% by weight, and from about 1% to about 10% by weight. Non-limiting examples of suitable zwitterionic or amphoteric surfactants are described in U.S. Pat. Nos. 5,104,646 and 5,106,609, which are incorporated herein by reference in their entirety.

[0107] Suitable amphoteric detersive surfactants for use in the hair care compositions include those surfactants broadly described as derivatives of aliphatic secondary and tertiary amines in which the aliphatic radical can be straight or branched chain and in which one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one aliphatic substituent contains an anionic group such as carboxyl, sulfonate, sulfate, phosphate or phosphonate. Exemplary amphoteric detersive surfactants for use in the hair care compositions of the present invention include cocoamphoacetate, cocoamphodiacetate, lauroamphoacetate, lauroamphodiacetate, and mixtures thereof.

[0108] Suitable zwitterionic detersive surfactants for use in hair care compositions include those broadly described as fatty quaternary ammonium, and matte Those surfactants that are derivatives of compounds wherein the aliphatic group may be straight or branched chain and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one aliphatic substituent contains an anionic group such as carboxyl, sulfonate, sulfate, phosphate or phosphonate. In another embodiment, a zwitterionizer is selected such as a betaine.

[0109] Other non-limiting examples of anionic, zwitterionic, amphoteric surfactants or optional additional surfactants suitable for use in the hair care compositions are described in McCutcheon's Emulsifiers and Detergents, 1989 Annual, MC and U.S. Pat. Nos. 3,929,678, 2,658,072, 2,438,091, 2,528,378, the entireties of which are incorporated herein by reference.

[0110] The hair care compositions may also comprise a shampoo gel base, an aqueous carrier, and other additional ingredients as described herein.

[0111] Aqueous carrier

[0112] The hair care composition may include a first aqueous carrier. The amount and type of carrier is selected based on compatibility with other components and other desired features of the product. Thus, formulations of the hair care composition may be in the form of a pourable liquid (under ambient conditions). Thus, such compositions will typically include a first aqueous carrier, which is present in an amount of at least 20% by weight, from about 20% by weight to about 95% by weight, or from about 60% by weight to about 85% by weight. The first aqueous carrier may include water, or a miscible mixture of water and an organic solvent, and in one aspect may include water and minimal or insignificant concentrations of organic solvents, except for those otherwise incidentally incorporated into the composition as minor ingredients of other components.

[0113] The first aqueous carrier that can be used in the hair care composition includes water and aqueous solutions of lower alkyl alcohols and polyols. The lower alkyl alcohols that can be used herein are monohydric alcohols having 1 to 6 carbons, in one aspect, ethanol and isopropanol. The polyols that can be used herein include propylene glycol, hexylene glycol, glycerol and propane diol.

[0114] In an embodiment of the present invention, the aqueous carrier is substantially water. In another embodiment, deionized water may be used. Water from natural sources containing mineral cations may also be used, depending on the desired characteristics of the product. Generally speaking, the compositions of the present invention comprise from about 0% to about 99%, from about 50% to about 95% in one embodiment, from about 70% to about 90% in another embodiment, and from about 80% to about 90% water in another embodiment.

[0115] Shampoo gel base

[0116] In an embodiment, the hair care compositions described herein may include a shampoo gel base. The shampoo gel base includes (i) from about 0.1% to about 20%, alternatively from about 0.5% to about 14%, alternatively from about 1% to about 10%, alternatively from about 6% to about 8% of one or more fatty alcohols, by weight of the shampoo gel base; (ii) from about 0.1% to about 10% of one or more shampoo gel base surfactants, by weight of the shampoo gel base; and (iii) from about 20% to about 95%, or from about 60% to about 85% of an aqueous carrier, by weight of the shampoo gel base.

[0117] Fatty alcohols useful herein are those having from about 10 to about 40 carbon atoms, from about 12 to about 22 carbon atoms, from about 16 to about 22 carbon atoms, or from about 16 to about 18 carbon atoms. These fatty alcohols can be straight chain alcohols or branched chain alcohols, and can be saturated or unsaturated. Non-limiting examples of fatty alcohols include cetyl alcohol, stearyl alcohol, behenyl alcohol, and mixtures thereof. A mixture of cetyl alcohol and stearyl alcohol in a ratio of about 20:80 to about 80:20 is suitable.

[0118] The aqueous carrier may comprise water, or a miscible mixture of water and an organic solvent, and in one aspect may comprise water and minimal or insignificant concentrations of organic solvents, except for those otherwise incidentally incorporated into the composition as minor ingredients of other components.

[0119] Aqueous carriers useful herein include water and aqueous solutions of lower alkyl alcohols and polyols. The lower alkyl alcohols useful herein are monohydric alcohols having 1 to 6 carbons, in one aspect, ethanol and isopropanol. Exemplary polyols useful herein include propylene glycol, hexylene glycol, glycerol, and propane diol.

[0120] Additional Ingredients

[0121] As mentioned above, skin conditioning agents, in particular these may be silicone conditioning agents and organic conditioning agents.

[0122] The hair care composition of the present invention may also further comprise a nonionic polymer. According to one embodiment, the conditioning agent used in the hair care composition of the present invention may comprise a polyalkylene glycol polymer. For example, polyalkylene glycols having a molecular weight greater than about 1000 may be used herein. Useful are those having the following general formula (VIII):

[0123]

[0124] Where R 11 is selected from H, methyl, and mixtures thereof; and v is the number of ethoxy units. Polyalkylene glycols such as polyethylene glycol may be included in the hair care compositions of the present invention at a level of from about 0.001 wt % to about 10 wt %. In one embodiment, the polyethylene glycol is present in an amount of up to about 5 wt % based on the weight of the composition. Polyethylene glycol polymers useful herein are PEG-2M (also known as Polyox N-10, available from Union Carbide and known as PEG-2,000); PEG-5M (also known as Polyox N-35 and Polyox N-80, available from UnionCarbide and known as PEG-5,000 and polyethylene glycol 300,000); PEG-7M (also known as Polyox N-750, available from Union Carbide); PEG-9M (also known as Polyox N-3333, available from Union Carbide); and PEG-14M (also known as Polyox N-3000, purchased from Union Carbide).

[0125] The hair care compositions of the present invention may also contain a deposition aid, such as a cationic polymer. Cationic polymers useful herein are those having an average molecular weight of at least about 5,000, alternatively from about 10,000 to about 10 million, alternatively from about 100,000 to about 2 million.

[0126] Suitable cationic polymers include, for example, copolymers of vinyl monomers having cationic amine or quaternary ammonium functional groups and water-soluble spacer monomers such as acrylamide, methacrylamide, alkyl and dialkyl acrylamides, alkyl and dialkyl methacrylamides, alkyl acrylates, alkyl methacrylates, vinyl caprolactone and vinyl pyrrolidone. Other suitable spacer monomers include vinyl esters, vinyl alcohol (prepared by hydrolysis of polyvinyl acetate), maleic anhydride, propylene glycol and ethylene glycol. Other suitable cationic polymers that can be used herein include, for example, cationic cellulose, cationic starch and cationic guar gum.

[0127] The cationic polymer may be included in the hair care compositions of the present invention at a level of from about 0.001% to about 10% by weight. In one embodiment, the cationic polymer is present in an amount up to about 5% by weight, based on the weight of the composition.

[0128] In an embodiment, the hair care composition further comprises one or more additional benefit agents. The benefit agents include materials selected from the group consisting of anti-dandruff agents, antifungal agents, anti-itch agents, antibacterial agents, antimicrobial agents, moisturizers, antioxidants, vitamins, fat-soluble vitamins, chelating agents, fragrances, whitening agents, enzymes, sensates, insect attractants, dyes, pigments, bleaching agents, and mixtures thereof.

[0129] The hair care composition may comprise an anti-dandruff active, which may be an anti-dandruff active microparticle. In one embodiment, the anti-dandruff active is selected from: pyridinethione salts; azoles, such as ketoconazole, econazole and econazole; selenium sulfide; microparticle sulfur; keratolytic agents, such as salicylic acid; and mixtures thereof. In one embodiment, the anti-dandruff microparticles are pyridinethione salts.

[0130] Pyridinethione microparticles are suitable microparticle anti-dandruff actives. In one embodiment, the anti-dandruff active is a 1-hydroxy-2-pyridinethione salt and is in microparticle form. In one embodiment, the concentration of the pyridinethione anti-dandruff microparticles is in the range of about 0.01 wt % to about 5 wt %, or about 0.1 wt % to about 3 wt %, or about 0.1 wt % to about 2 wt %. In one embodiment, the pyridinethione salt is formed by heavy metals such as zinc, tin, cadmium, magnesium, aluminum and zirconium (usually zinc), usually the zinc salt of 1-hydroxy-2-pyridinethione (called "zinc pyridinethione" or "ZPT"), usually 1-hydroxy-2-pyridinethione salt in the form of flaky particles. In one embodiment, the 1-hydroxy-2-pyridinethione salt in the form of flaky particles has an average particle size of up to about 20 microns, or up to about 5 microns, or up to about 2.5 microns. Salts formed by other cations such as sodium may also be suitable. Pyridinethione anti-dandruff actives are described, for example, in U.S. Pat. No. 2,809,971, U.S. Pat. No. 3,236,733, U.S. Pat. No. 3,753,196, U.S. Pat. No. 3,761,418, U.S. Pat. No. 4,345,080, U.S. Pat. No. 4,323,683, U.S. Pat. No. 4,379,753, and U.S. Pat. No. 4,470,982.

[0131] In one embodiment, the composition comprises, in addition to the anti-dandruff active selected from the polyvalent metal salts of pyridinethione, one or more antifungal and / or antimicrobial actives. In one embodiment, the antimicrobial active is selected from the group consisting of coal tar, sulfur, charcoal, benzoic acid ointment, castellani's paint, aluminum chloride, gentian violet, hydroxymethyl octopirox (piroctone olamine salt), ciclopirox olamine, undecylenic acid and its metal salts, potassium permanganate, selenium sulfide, sodium thiosulfate, propylene glycol, bitter orange oil, urea preparations, griseofulvin, 8-hydroxyquinoline clioquinol, thiodibutazole, thiocarbamates, haloprogin, polyenes, hydroxypyridone, morpholine, benzylamine, allylamine (such as terbinafine), tea tree oil, clove leaf oil, coriander, palmarosa, berberine, thyme red, cinnamon oil, cinnamaldehyde, citronellal acid, hinokitiol, shale oil, Sensiva SC-50, Elestab HP-100, azelaic acid, lytic enzymes, iodopropynyl butylcarbamate (IPBC), isothiazolinones such as octylisothiazolinone, and azoles, and mixtures thereof. In one embodiment, the antimicrobial agent is selected from: itraconazole, ketoconazole, selenium sulfide, coal tar, and mixtures thereof.

[0132] The azole antimicrobial agent can be an imidazole as at least one of the following items: benzimidazole, benzothiazole, bifonazole, butoconazole nitrate, climbazole, clotrimazole, cloconazole, eberconazole, econazole, new conazole, fenticonazole, fluconazole, flutrimazole, isoconazole, ketoconazole, lannoconazole, metronidazole, miconazole, neticonazole, omoconazole, oxiconazole nitrate, sertaconazole, sulconazole nitrate, tioconazole, thiazole and their mixtures, or the azole antimicrobial agent is a triazole selected from the following items: terconazole, itraconazole and their mixtures. When present in the hair care composition, the azole antimicrobial active material is included in an amount of about 0.01% by weight to about 5% by weight, or about 0.1% by weight to about 3% by weight, or about 0.3% by weight to about 2% by weight. In one embodiment, the azole antimicrobial active material is ketoconazole. In one embodiment, the only antimicrobial active material is ketoconazole.

[0133] Embodiments of the hair care composition may also include a combination of antimicrobial actives. In one embodiment, the combination of antimicrobial actives is selected from the group consisting of octopirox and zinc pyrithione, pine tar and sulfur, salicylic acid and zinc pyrithione, salicylic acid and succinimidyl, zinc pyrithione and succinimidyl, zinc pyrithione and imipenem, octopirox and imipenem, salicylic acid and octopirox, and mixtures thereof.

[0134] In an embodiment, the composition comprises an effective amount of a zinc-containing layered material. In one embodiment, the composition comprises from about 0.001 wt % to about 10 wt %, or from about 0.01 wt % to about 7 wt %, or from about 0.1 wt % to about 5 wt % of a zinc-containing layered material based on the total weight of the composition.

[0135] Zinc-containing layered materials can be those with crystal growth mainly in a two-dimensional plane. Conventionally, layered structures are described as those in which not only all atoms are incorporated into well-defined layers, but also those in which ions or molecules called tunnel ions (AF Wells, "Structural Inorganic Chemistry" Clarendon Press, 1975) are present between layers. Zinc-containing layered materials (ZLMs) can have zinc incorporated into the layers and / or components that can serve as tunnel ions. The following categories of ZLMs represent relatively common examples in the general category and are not intended to limit the wider range of materials that meet this definition.

[0136] Many ZLMs occur in the form of minerals in nature. In embodiments, the ZLM can be at least one of the following: hydrozincite (zinc carbonate hydroxide), chalcocite (zinc carbonate copper hydroxide), chalcocite (copper carbonate zinc hydroxide), and mixtures thereof. Related zinc-containing minerals may also be included in the composition. Natural ZLMs may also exist, wherein anionic layer materials such as clay-type minerals (e.g., phyllosilicates) contain ion-exchanged zinc tunnel ions. All of these natural materials may also be obtained by synthesis, or formed in situ in the composition or during the production process.

[0137] Another common class of ZLMs (which may be synthetic) are layered binary hydroxides. In one embodiment, the ZLM is a compound conforming to the formula [M 2+ 1-x M 3+ x (OH)2] x+ A m- x / m nH2O layered binary hydroxides, in which the divalent ions (M 2+ ) are some or all zinc ions (Crepaldi, EL, Pava, PC, Tronto, J, Valim, JB J. Colloid Interfac. Sci. 2002, 248, 429-42).

[0138] Another class of ZLMs can be prepared, known as hydroxy double salts (Morioka, H., Tagaya, H., Karasu, M, Kadokawa, J, Chiba, K Inorg. Chem. 1999, 38, 4211-6). In one embodiment, the ZLM is a compound of formula [M 2 + 1-x M 2+ 1+x (OH) 3(1-y) ] + A n- (1=3y) / n ·nH2O hydroxyl salt, in which two metal ions (M 2+ ) may be the same or different. If they are the same and are represented by zinc, the formula is simplified to [Zn 1+x (OH)2] 2x+ 2x A - nH2O. The latter formula represents (where x=0.4) materials such as zinc hydroxychloride and basic zinc nitrate. In one embodiment, the ZLM is zinc hydroxychloride and / or basic zinc nitrate. These are also related to hydrozincite, where a divalent anion replaces a monovalent anion. These materials may also be formed in the composition or in situ during or in the production process.

[0139] In embodiments having a zinc-containing layered material and pyridinethione or a polyvalent metal salt of pyridinethione, the ratio of the zinc-containing layered material to pyridinethione or a polyvalent metal salt of pyridinethione is from about 5:100 to about 10:1, or from about 2:10 to about 5:1, or from about 1:2 to about 3:1.

[0140] The anti-dandruff active has a scalp deposit of at least about 1 μg / cm 2 To ensure that the anti-dandruff active reaches the scalp where it can perform its function, the deposition of the anti-dandruff active on the scalp is important. In one embodiment, the deposition of the anti-dandruff active on the scalp is at least about 1.5 μg / cm 2 , or at least about 2.5 μg / cm 2 , or at least about 3 μg / cm 2 , or at least about 4 μg / cm 2 , or at least about 6 μg / cm 2 , or at least about 7 μg / cm 2 , or at least about 8 μg / cm 2 , or at least about 8 μg / cm 2 , or at least about 10 μg / cm 2 The deposition of anti-dandruff active on the scalp is measured by a professional beautician washing the hair of an individual with a composition comprising an anti-dandruff active, such as a composition according to the present invention, according to a conventional washing regimen. The hair on the scalp area is then separated to allow an open-ended glass measuring cylinder to remain on the surface while an aliquot of the extraction solution is added and stirred, then recovered and the anti-dandruff active content is determined by conventional methods such as HPLC analysis.

[0141] In an embodiment, the rinse-off hair care composition may include a rheology modifier. The rheology modifier increases the directness and stability of the composition, improving the feel and consumer experience (e.g., no dripping, spreadability, etc.). Any suitable rheology modifier may be used. In one embodiment, the hair care composition may include from about 0.05% to about 10% of a rheology modifier, in another embodiment, from about 0.1% to about 10% of a rheology modifier, in yet another embodiment, from about 0.5% to about 2% of a rheology modifier, in another embodiment, from about 0.7% to about 2% of a rheology modifier, and in another embodiment, from about 1% to about 1.5% of a rheology modifier. In one embodiment, the rheology modifier may be a polyacrylamide thickener. In one embodiment, the rheology modifier may be a polymeric rheology modifier.

[0142] In an embodiment, the rinse-off hair care composition may include a rheology modifier that is a homopolymer based on acrylic acid, methacrylic acid or other related derivatives, non-limiting examples of which include polyacrylates, polymethacrylates, polyethylacrylates, and polyacrylamides.

[0143] In an embodiment, the rheology modifier may be an alkali-swellable and hydrophobically modified alkali-swellable acrylic copolymer or methacrylate copolymer, non-limiting examples of which include acrylic acid / acrylonitrile copolymer, acrylates / stearyl polyeth-20 itaconate copolymer, acrylates / cetyl polyeth-20 itaconate copolymer, acrylates / aminoacrylate copolymer, acrylates / stearyl polyeth-20 methacrylate copolymer, acrylates / beheneth-25 methacrylate copolymer, acrylates / stearyl polyeth-20 methacrylate crosspolymer, acrylates / vinyl neodecanoate crosspolymer, and acrylates / C10-C30 alkyl acrylate crosspolymer.

[0144] In embodiments, the rheology modifier may be a cross-linked acrylic polymer, non-limiting examples of which include carbomers.

[0145] In embodiments, the rheology modifier may be an alginic acid based material; non-limiting examples include sodium alginate and propylene glycol alginate.

[0146] In an embodiment, the rheology modifier may be: an associative polymer thickener, non-limiting examples of which include: a hydrophobically modified cellulose derivative; a hydrophobically modified alkoxylated urethane polymer, non-limiting examples of which include PEG-150 / decyl alcohol / SMDI copolymer, PEG-150 / stearyl alcohol / SMDI copolymer, polyurethane-39; a hydrophobically modified alkali swellable emulsion, non-limiting examples of which include hydrophobically modified polyacrylates, hydrophobically modified polyacrylic acids, and hydrophobically modified polyacrylamides; a hydrophobically modified polyether, wherein these materials may have a hydrophobe that may be selected from cetyl, stearyl, oleyl, and combinations thereof, and a hydrophilic portion having 10 to 300, in another embodiment 30 to 200, and in another embodiment 40 to 150 repeating units of repeating ethylene oxide groups. Non-limiting examples of this class include PEG-120-methylglucose dioleate, PEG-(40 or 60) sorbitan tetraoleate, PEG-150 pentaerythritol tetrastearate, PEG-55 propylene glycol oleate, PEG-150 distearate.

[0147] In embodiments, the rheology modifier may be cellulose and derivatives; non-limiting examples include microcrystalline cellulose, carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, methyl cellulose, ethyl cellulose, nitro cellulose, cellulose sulfate, cellulose powder, and hydrophobically modified cellulose.

[0148] In embodiments, the rheology modifier may be guar gum and guar gum derivatives; non-limiting examples include hydroxypropyl guar and hydroxypropyl guar hydroxypropyltrimonium chloride.

[0149] In embodiments, the rheology modifier may be polyethylene oxide, polypropylene oxide, and POE-PPO copolymers.

[0150] In an embodiment, the rheology modifier may be polyvinyl pyrrolidone, cross-linked polyvinyl pyrrolidone, and derivatives. In another embodiment, the rheology modifier may be polyvinyl alcohol and derivatives.

[0151] In embodiments, the rheology modifier may be polyethyleneimine and derivatives.

[0152] In embodiments, the rheology modifier may be silica; non-limiting examples include fumed silica, precipitated silica, and silicone surface treated silica.

[0153] In embodiments, the rheology modifier may be a water swellable clay, non-limiting examples of which include laponite, bentonite, montmorillonite, smectite, and hectorite.

[0154] In embodiments, the rheology modifier may be a gum, non-limiting examples of which include xanthan gum, guar gum, hydroxypropyl guar gum, gum arabic, gum tragacanth, galactan, carob gum, karaya gum, and locust bean gum.

[0155] In an embodiment, the rheology modifier can be dibenzylidene sorbitol, carrageenan, pectin, agar, quince seeds (quince), starch (from rice, corn, potato, wheat, etc.), starch derivatives (e.g., carboxymethyl starch, methylhydroxypropyl starch), algae extract, dextran, succinoglucan and pulleran.

[0156] In embodiments, the compositions of the present invention may include suspending agents, including crystalline suspending agents that can be classified as acyl derivatives, long-chain amine oxides, and mixtures thereof. These suspending agents are described in U.S. Pat. No. 4,741,855. These suspending agents include ethylene glycol esters of fatty acids having about 16 to about 22 carbon atoms in one aspect. In one aspect, available suspending agents include ethylene glycol stearate, both monostearate and distearate, but in one aspect, distearate contains less than about 7% monostearate. Other suitable suspending agents include alkanolamides of fatty acids having about 16 to about 22 carbon atoms, or even about 16 to 18 carbon atoms, examples of which include stearyl monoethanolamide, stearyl diethanolamide, stearyl monoisopropanolamide, and stearyl monoethanolamide stearate. Other long-chain acyl derivatives include long-chain esters of long-chain fatty acids (e.g., stearyl stearate, cetyl palmitate, etc.); long-chain esters of long-chain alkanolamides (e.g., stearamide diethanolamide distearate, stearamide monoethanolamide stearate); and glycerides (e.g., glyceryl distearate, glyceryl trihydroxystearate, glyceryl tribehenate), commercial examples of which are available from Rheox, Inc. R. In addition to the materials listed above, long-chain acyl derivatives, glycol esters of long-chain carboxylic acids, long-chain amine oxides, and alkanolamides of long-chain carboxylic acids can be used as suspending agents. Other long-chain acyl derivatives suitable for use as suspending agents include N, N-dialkyl amidobenzoic acid and its soluble salts (e.g., Na, K), especially N, N-di(hydrogenated) C16, C18 and tallow amidobenzoic acid, which are commercially available from Stepan Company (Northfield, Ill., USA). Examples of suitable long-chain amine oxides for use as suspending agents include alkyl dimethyl amine oxides, such as stearyl dimethyl amine oxide. Other suitable suspending agents include primary amines having a fatty alkyl portion containing at least about 16 carbon atoms (examples of which include palmitylamine or octadecylamine) and secondary amines having two fatty alkyl portions each containing at least about 12 carbon atoms (examples of which include dipalmitoylamine or di(hydrogenated tallow)amine). Other suitable suspending agents include di(hydrogenated tallow)phthalic acid amide and crosslinked maleic anhydride-methyl vinyl ether copolymer.

[0157] Non-limiting examples of rheology modifiers include acrylamide / ammonium acrylate copolymer (and) polyisobutylene (and) polysorbate 20, acrylamide / sodium acryloyldimethyltaurate copolymer / isohexadecane / polysorbate 80, acrylates copolymer; acrylates / beheneth-25 methacrylate copolymer, acrylates / C10-C30 alkyl acrylate crosspolymer, acrylates / stearyl polyoxyethylene itaconate copolymer, ammonium polyacrylate / isohexadecane / PEG-40 castor oil, C12-16 alkyl PEG-2 hydroxypropyl hydroxyethyl ethylcellulose (HM-EHEC), carbomer, cross-linked polyvinyl pyrrolidone (PVP), dibenzylidene sorbitol, hydroxyethyl ethylcellulose (EHEC), hydroxypropyl methylcellulose cellulose (HPMC), hydroxypropyl methylcellulose (HPMC), hydroxypropyl cellulose (HPC), methylcellulose (MC), methyl hydroxyethyl cellulose (MEHEC), PEG-150 / decyl alcohol / SMDI copolymer, PEG-150 / stearyl alcohol / SMDI copolymer, polyacrylamide / C13-14 isoparaffin / laureth-7; polyacrylate 13 / polyisobutylene / polysorbate 20; polyacrylate crosspolymer-6, polyamide-3; polyquaternium-37 (and) hydrogenated polydecene (and) tridecyl polyoxyethylene ether-6, polyurethane-39, sodium acrylate / sodium acryloyldimethyl taurate / dimethylacrylamide, crosspolymer (and) isohexadecane (and) polysorbate 60; sodium polyacrylate. Exemplary commercially available rheology modifiers include ACULYN TM 28. Klucel TM M CS, Klucel TM H CS, Klucel TM G CS, SYLVACLEAR TM AF1900V、SYLVACLEAR TM PA1200V, Benecel TM E10M、Benecel TM K35M, Optasense TM RMC70、ACULYN TM 33. ACULYN TM 46. ​​ACULYN TM 22. ACULYN TM 44. Carbopol Ultrez TM 20. Carbopol Ultrez TM 21. Carbopol Ultrez TM 10. Carbopol Ulterez TM 30. Carbopol TM1342. Carbopol TM 934.Carbopol TM 940、Carbopol TM 950、Carbopol TM 980 and Carbopol TM 981、Acrysol TM 22. Sepigel TM 305.Simulgel TM 600, Sepimax Zen, Simulquat HC 305 and their combinations.

[0158] Personal care compositions

[0159] The capsules of the present invention can be used in personal care compositions to provide one or more benefits, including freshness and / or softness. Personal care compositions are intended for topical application to the skin, including prescription topical medications, over-the-counter medications, behind-the-counter medications, cosmetics, consumer products, and combinations thereof. The personal care compositions of the present invention can be in different forms. Non-limiting examples of the forms are: bar soaps, body washes, moisturizing body washes, shower gels, skin cleansers, cleansing milks, bath moisturizers, shaving preparations, cleaning compositions used in conjunction with disposable cleansing cloths, sprays, liquids, pastes, Newtonian or non-Newtonian fluids, gels, and sols.

[0160] The personal care composition may comprise a capsule having at least one benefit agent at a level that promotes one or more benefits upon immediate use. In embodiments of the present invention, the personal care composition may comprise from about 0.01% to about 15% by weight of at least one benefit agent encapsulated in the capsule. In embodiments, the personal care composition may comprise from about 0.05% to about 8% of the encapsulated at least one benefit agent. In embodiments, the personal care composition may comprise from about 0.1% to about 5% of at least one encapsulated benefit agent.

[0161] In addition to the capsules, the personal care compositions of the present invention may further comprise additional ingredients.

[0162] The personal care composition can be multi-phase or single-phase. Although for simplicity, the components of the personal care composition will be discussed below as multi-phase, the components of each phase can also be used in a single phase. The personal care composition can include a cleansing phase and a benefit phase. The cleansing phase and the benefit phase can be mixed. The cleansing phase and the benefit phase can also be patterned (e.g., striped and / or marbled). In one aspect, the cleansing phase can include capsules. In another aspect, the benefit phase can include capsules.

[0163] Cleaning phase

[0164] The personal care composition may comprise from about 50% to about 99.5% of a cleansing phase by weight of the composition. The cleansing phase may comprise a surfactant. The personal care composition may also comprise from 2% to 20% of a surfactant by weight of the rinse-off personal care composition. The surfactant may comprise an anionic surfactant, a nonionic surfactant, an amphoteric surfactant, a zwitterionic surfactant, a cationic surfactant, or a mixture thereof. The personal care composition may comprise at least one anionic surfactant. The personal care composition may also comprise, for example, an anionic surfactant, an amphoteric surfactant, and a zwitterionic surfactant. Suitable amphoteric or zwitterionic surfactants may, for example, be included in those described in U.S. Patent No. 5,104,646 and U.S. Patent No. 5,106,609.

[0165] Anionic surfactants suitable for use in the cleansing phase of the present compositions include alkyl sulfates and alkyl ether sulfates. These materials have the corresponding formulas ROSO3M and RO(C2H4O) x SO3M, wherein R is an alkyl or alkenyl group of about 8 to about 24 carbon atoms, wherein x is from about 1 to about 10, and M is a water-soluble cation such as ammonium, sodium, potassium or triethanolamine. Alkyl ether sulfates are generally prepared as condensation products of ethylene oxide and monohydric alcohols having from about 8 to about 24 carbon atoms. In alkyl sulfates and alkyl ether sulfates, R may have from about 10 to about 18 carbon atoms. Alcohols may be derived from fats, such as coconut oil or tallow, or may be synthetic. Lauryl alcohol and straight-chain alcohols derived from coconut oil may be used. Such alcohols may be partially reacted with about 1 mole or about 3 moles to about 10 moles or about 5 moles of ethylene oxide precursors. The resulting mixture of molecular species may have, for example, an average of 3 moles of ethylene oxide per mole of alcohol being sulfated and neutralized.

[0166] Specific examples of alkyl ether sulfates that can be used in the cleansing phase are the sodium and ammonium salts of coconut alkyl triethylene glycol ether sulfate; tallow alkyl triethylene glycol ether sulfate and tallow alkyl hexaoxyethylene sulfate. Suitable alkyl ether sulfates are those comprising a mixture of individual compounds having an average alkyl chain length of from about 10 to about 16 carbon atoms and an average degree of ethoxylation of from about 1 to about 4 moles of ethylene oxide.

[0167] Other suitable anionic surfactants include those having the general formula [R 1 -SO3-M] organic sulfuric acid reaction product, wherein R 1is selected from a straight or branched chain saturated aliphatic hydrocarbon radical having from about 8 to about 24 or from about 10 to about 18 carbon atoms; and M is a cation. Suitable examples are salts of organic sulfuric acid reaction products of hydrocarbons of the methane series, including isoparaffins, neoparaffins, neoisoparaffins and normal paraffins, having from about 8 to about 24 carbon atoms, preferably from about 10 to about 18 carbon atoms, and sulfonating agents such as SO3, H2SO4, oleum, obtained according to known sulfonation processes, including bleaching and hydrolysis. Preferred are sulfonated C 10-18 Alkali metal and ammonium salts of n-alkanes.

[0168] Suitable anionic surfactants for use in the cleansing phase include ammonium lauryl sulfate, ammonium polyoxyethylene lauryl ether sulfate, triethylamine lauryl sulfate, triethylamine polyoxyethylene lauryl ether sulfate, triethanolamine lauryl sulfate, triethanolamine polyoxyethylene lauryl ether sulfate, monoethanolamine lauryl sulfate, monoethanolamine polyoxyethylene lauryl ether sulfate, diethanolamine lauryl sulfate, diethanolamine polyoxyethylene lauryl ether sulfate, sodium lauric acid monoglyceride sulfate, sodium lauryl sulfate, sodium lauryl polyoxyethylene ether sulfate, potassium lauryl polyoxyethylene ether sulfate, sodium lauryl sarcosinate, sodium lauroyl sarcosinate, lauryl sarcosine, cocoyl sarcosine, ammonium cocoyl sulfate, ammonium lauroyl sulfate, sodium cocoyl sulfate, sodium lauroyl sulfate, potassium cocoyl sulfate, potassium lauryl sulfate, monoethanolamine cocoyl sulfate, sodium tridecylbenzene sulfonate, sodium dodecylbenzene sulfonate, and combinations thereof.

[0169] Anionic surfactants having branched alkyl chains, such as sodium trideceth sulfate, may be used. Mixtures of anionic surfactants may also be used.

[0170] Amphoteric surfactants may include those broadly described as derivatives of aliphatic secondary and tertiary amines, wherein the aliphatic radical may be straight or branched chain, and wherein the aliphatic substituent may contain from about 8 to about 18 carbon atoms, such that one carbon atom may contain a water-solubilizing anionic group, e.g., a carboxyl, sulfonate, sulfate, phosphate, or phosphonate. Examples of compounds falling within this definition may be sodium 3-dodecylaminopropionate, sodium 3-dodecylaminopropane sulfonate, sodium lauryl sarcosinate, N-alkyltaurines (such as those prepared by reacting dodecylamine with sodium isethionate according to the teachings in U.S. Pat. No. 2,658,072), N-higher alkyl aspartic acids (such as those produced according to the teachings in U.S. Pat. No. 2,438,091), and the products described in U.S. Pat. No. 2,528,378. Other examples of amphoteric surfactants can include sodium lauroamphoacetate, sodium cocoamphoacetate, disodium lauroamphoacetate, disodium cocoamphoacetate, and mixtures thereof. Amphoacetates and diamphoacetates can also be used.

[0171] Suitable zwitterionic surfactants for use as cleansing surfactants in the structured aqueous cleansing phase include those broadly described as fatty quaternary ammonium, and derivatives of sulfonium compounds in which the aliphatic radical may be straight or branched chain and in which one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic group such as carboxyl, sulfonate, sulfate, phosphate or phosphonate.

[0172] Other zwitterionic surfactants suitable for use in the cleansing phase include betaines, including higher alkyl betaines such as cocodimethylcarboxymethyl betaine, cocamidopropyl betaine, cocobetaine, laurylamidopropyl betaine, oleyl betaine, lauryldimethylcarboxymethyl betaine, lauryldimethyl alpha-carboxyethyl betaine, cetyldimethylcarboxymethyl betaine, lauryl bis-(2-hydroxyethyl)carboxymethyl betaine, stearyl bis-(2-hydroxypropyl)carboxymethyl betaine, oleyldimethyl gamma-carboxypropyl betaine and lauryl bis-(2-hydroxypropyl) alpha-carboxyethyl betaine. Sulfobetaine can be represented by the following: cocodimethyl sulfopropyl betaine, stearyl dimethyl sulfopropyl betaine, lauryl dimethyl sulfoethyl betaine, lauryl bis-(2-hydroxyethyl) sulfopropyl betaine, etc.; amidobetaines and amidosulfobetaines can also be used in the composition of the present invention, wherein the RCONH(CH2)3 free radical is attached to the nitrogen atom of the betaine.

[0173] Amphoacetates and diamphoacetates may also be used. Non-limiting examples of suitable amphoacetates and diamphoacetates include sodium lauroamphoacetate, sodium cocoamphoacetate, disodium lauroamphoacetate, and disodium cocodiamphoacetate.

[0174] Cationic surfactants may also be used in the cleansing phase and may comprise from 2% to about 5% by weight of the cleansing phase.

[0175] Suitable nonionic surfactants for use in the structured aqueous cleansing phase include condensation compounds of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic compound which may be aliphatic or alkyl aromatic in nature.

[0176] Other suitable surfactants or co-surfactants that are generally useful in the cleansing phase of rinse-off personal care compositions are described in McCutcheon's Detergents and Emulsifiers, North American Edition (Allured Publishing Corporation 1947) (1986), McCutcheon's Functional Materials, North American Edition (Allured Publishing Corporation 1973) (1992), and U.S. Pat. No. 3,929,678, filed Aug. 1, 1974.

[0177] The cleaning phase may include a structured surfactant. Such a structured surfactant may be included in an amount of 2% to about 20% by weight of the personal care composition; about 3% to about 15% by weight of the personal care composition; or about 5% to about 10% by weight of the personal care composition. Such structured surfactants may include sodium trideceth(n) sulfate (hereinafter STnS), wherein n defines the average number of moles of ethoxylation. For example, n may range from about 0 to about 3; n may range from about 0.5 to about 2.7; about 1.1 to about 2.5; about 1.8 to about 2.2; or n may be about 2. When n is less than 3, STnS may provide improved stability, improved compatibility of benefit agents in rinse-off personal care compositions, and / or increased mildness of rinse-off personal care compositions, such STnS benefits described are disclosed in U.S. Patent Application Publication No. 2012 / 0009285.

[0178] The personal care composition may also contain from about 2% to 20% by weight of the personal care composition of a co-surfactant. The co-surfactant may include an amphoteric surfactant, a zwitterionic surfactant, or a mixture thereof. Examples of these types of surfactants are described above.

[0179] The personal care composition may also include a water-soluble cationic polymer. The water-soluble cationic polymer may be present at about 0.001% to about 3% by weight of the personal care composition. The water-soluble cationic polymer may be present at about 0.05% to about 2% by weight of the personal care composition. The water-soluble cationic polymer may also be present at about 0.1% to about 1% by weight of the personal care composition. The polymer may be present in one or more phases as a deposition aid for the benefit agents described herein. Cationic deposition polymers suitable for use in the compositions of the present invention include, for example, cationic nitrogen-containing moieties (such as quaternary ammonium) or cationic protonated amino moieties. Depending on the specific type of personal care composition and the selected pH, the cationic protonated amine may be a primary amine, a secondary amine, or a tertiary amine.

[0180] Non-limiting examples of cationic deposition polymers for use in the composition may include polysaccharide polymers such as cationic cellulose derivatives. Cationic cellulose polymers may be, for example, salts of hydroxyethylcellulose reacted with trimethylammonium substituted epoxides, known in the industry (CTFA) as polyquaternium 10, available from Amerchol Corp. (Edison, NJ, USA) in their polymer KG, JR and LR polymer series. Water-soluble cationic polymers include, for example, KG-30M. Other suitable cationic deposition polymers include cationic guar gum derivatives, such as guar hydroxypropyltrimonium chloride, specific examples of which include the Jaguar series commercially available from Rhodia Inc. (preferably Jaguar C-17) and the N-Hance polymer series commercially available from Ashland.

[0181] The water-soluble cationic polymer may include, for example, cationic guar gum. In one example, the cationic guar gum includes guar hydroxypropyltrimonium chloride. Guar hydroxypropyltrimonium chloride may include, for example, N-hance TM CG-17 cationic guar gum. The cationic guar gum may be, for example, selected from the group consisting of: N-hance TM 3196, Jaguar C-500, Jaguar C-17, and combinations thereof. The deposition polymer may have a cationic charge density of about 0.8 meq / g to about 2.0 meq / g, or about 1.0 meq / g to about 1.5 meq / g, or about 0.96 meq / g.

[0182] The water-soluble cationic polymer may also include synthetic polyacrylamides. Examples of suitable synthetic polyacrylamides include polyquaternium 76 and polymethylene-bis-acrylamide methacrylamidopropyl trimethylammonium chloride (PAMMAPTAC, AM:MAPTAC ratio of 88:12). In one example, the water-soluble cationic polymer includes PAM / MAPTAC.

[0183] The cleansing phase of the personal care composition may also include an associative polymer. Such an associative polymer may be a cross-linked alkali-swellable associative polymer comprising an acidic monomer and an associative monomer having a hydrophobic end group, such that the associative polymer has a hydrophobic modification percentage and hydrophobic side chains comprising alkyl functional groups. Without being limited by theory, it is believed that the acidic monomer may contribute to the ability of the associative polymer to swell in water upon neutralization of the acidic groups; and the associative monomer anchors the associative polymer to the structured surfactant hydrophobic domain, such as the hydrophobic layer, to impart structure to the surfactant phase and prevent the associative polymer from collapsing and losing effectiveness in the presence of electrolytes.

[0184] The crosslinked associative polymer may have a hydrophobic modification percentage, which is the molar percentage of the monomer, expressed as a percentage of the total number of all monomers in the polymer backbone, including acidic and other non-acidic monomers. The hydrophobic modification percentage (hereinafter HM%) of the associative polymer may be determined by the ratio of monomers added during synthesis or by analytical techniques such as proton nuclear magnetic resonance (NMR). The associative alkyl side chains may include, for example, butyl, propyl, stearyl, stearyl polyoxyethylene ether, hexadecyl, lauryl, lauryl polyoxyethylene ether, octyl, behenyl, behenyl alcohol polyoxyethylene ether, stearyl polyoxyethylene ether, or other linear, branched, saturated or unsaturated alkyl or alkyl polyoxyethylene ether hydrocarbon side chains. The acidic monomer may contain any acidic functional group, such as sulfate, sulfonate, carboxylate, phosphonate, or phosphate, or a mixture of acidic groups. The acidic monomer may include, for example, carboxylate, alternatively, the acidic monomer is an acrylate, including acrylic acid and / or methacrylic acid. The acidic monomers contain a polymerizable structure, for example, a vinyl functional group. Mixtures of acidic monomers such as acrylic and methacrylic monomer mixtures are useful.

[0185] The associative monomer may comprise a hydrophobic end group and a polymerizable component, such as a connectable vinyl group. The hydrophobic end group may be connected to the polymerizable component and thus to the polymer chain by different methods, but may be connected by ether or ester or amide functional groups, such as alkyl acrylate or vinyl alkanoate monomers. The hydrophobic end group may also be separated from the chain by, for example, an alkoxy ligand such as an alkyl ether. The associative monomer may be, for example, an alkyl ester, an alkyl (meth)acrylate, wherein (meth)acrylate is understood to mean methacrylate or acrylate, or a mixture of the two.

[0186] The hydrophobic end groups of the associative polymers may be incompatible with the aqueous phase of the composition and may associate with the lathering surfactant hydrophobic component. Without being limited by theory, it is believed that longer alkyl chains of the hydrophobic end groups of the structured polymers may increase incompatibility with the aqueous phase to enhance structure, while shorter alkyl chains of carbon numbers nearly similar to the lathering surfactant hydrophobe (e.g., 12 to 14 carbons) or multiple lathering surfactant hydrophobes (e.g., bilayer) may also be effective. The combination of the ideal range of hydrophobic end group carbon numbers and the optimal percentage of hydrophobic monomer expressed as a percentage of the polymer backbone may provide increased structure to the lathering, structured surfactant at low levels of polymer structurant.

[0187] The associative polymer may be Aqupec SER-300, prepared by Sumitomo Seika of Japan, which is an acrylate / C10-30 alkyl acrylate crosspolymer and contains stearyl side chains having less than about 1% HM. Other preferred associative polymers may contain stearyl, octyl, decyl, and lauryl side chains. Preferred associative polymers are Aqupec SER-150 (acrylate / C10-30 alkyl acrylate crosspolymer) containing about C18 (stearyl) side chains and about 0.4% HM and Aqupec HV-701EDR containing about C8 (octyl) side chains and about 3.5% HM. For another example, the associative polymer may be an acrylic acid / vinyl isodecanoate crosspolymer (Stabylen) 30 manufactured by 3V Sigma SpA, which has branched isodecanoate hydrophobic associative side chains.

[0188] Other optional additives may be included in the cleansing phase, including, for example, emulsifiers (eg, nonionic emulsifiers) and electrolytes. Suitable emulsifiers and electrolytes are described in US Patent Application Serial No. 13 / 157,665.

[0189] Beneficial

[0190] As indicated herein, the personal care composition may include a benefit phase. The composition may include from about 0.1% to about 50% of a benefit phase by weight of the composition. The benefit phase may be hydrophobic and / or anhydrous. The benefit phase may also be substantially free of surfactant or free of surfactant. Specifically, the benefit phase may include from about 0.1% to about 50% of a benefit agent by weight of the rinse-off personal care composition. The benefit phase may include, for example, from about 0.5% to about 20% of a skin conditioning agent by weight of the rinse-off personal care composition, as defined previously. The skin conditioning agent is preferably selected from the group of benefit agents.

[0191] The beneficial phase may have a particle size of about 4 μm to about 500 μm, about 5 μm to about 300 μm, about 6 μm to about 100 μm, or about 10 μm to about 50 μm. The particle size in the pure product is measured under a differential interference contrast optical microscope with a 10x objective. The particle size distribution is counted manually. In this application, it is assumed that all beneficial phase particles are uniform spheres. For irregularly shaped beneficial phase particles, the longest axis is used as the diameter of the particle size distribution count. The number-weighted average of all lipid particles is defined as the average lipid particle size. This measurement can also be completed with a computer algorithm.

[0192] The benefit phase may have a viscosity measured by a standard rheometer such as a Brookfield R / S plus. -1The shear rate is measured at 25° C. for a 2.5 mL sample. The benefit phase may generally have a viscosity of from about 200 cP to about 15,000 cP.

[0193] However, it has been found that a lower viscosity benefit phase (i.e., less than about 2000 cP) can be advantageous for manufacturing because it is easier to blend the benefit phase and the surfactant phase. Thus, for example, the benefit phase has a viscosity of 200 cP to about 1800 cP or about 300 cP to about 1500 cP.

[0194] Additional Ingredients

[0195] Additional ingredients may be added to personal care compositions to treat skin and / or hair, or to change the aesthetics of the personal care compositions, such as in the case of fragrances, colorants, dyes, etc. The materials that can be used in the products herein can be classified and described according to their cosmetic and / or therapeutic benefits or their assumed modes of action or functions. However, it should be understood that in some cases, active substances and other materials that can be used herein can provide more than one cosmetic and / or therapeutic benefits or functions, or act via more than one mode of action. Therefore, the classification herein can be performed for convenience, and it is not intended to limit the ingredients to one or more applications specifically indicated listed. The exact nature of these additional materials and their incorporation levels will depend on the physical form of the composition and the nature of the cleaning operation for which it will be used. The additional materials can typically be formulated with about 6% or less, about 5% or less, about 4% or less, about 3% or less, about 2% or less, about 1% or less, about 0.5% or less, about 0.25% or less, about 0.1% or less, about 0.01% or less, or about 0.005% or less of the rinse-off personal care composition.

[0196] For further improving the stability under stress conditions (such as high temperature and vibration), the density of the individual phases can be adjusted so that they can be substantially equivalent. In order to achieve this, low-density microspheres can be added to one or more phases of the rinse-off type personal care composition. The example of the rinse-off type personal care composition comprising low-density microspheres is described in the patent application entitled "Striped Liquid Personal Cleansing Compositions Containing A Cleansing Phase and A Separate Phase with Improved Stability" published on May 13, 2004 with U.S. Patent Publication No. 2004 / 0092415A1 filed by Focht et al. on October 31, 2003.

[0197] Other non-limiting ingredients that can be used in the personal care compositions of the present invention can include optional benefit components that can be selected from thickeners; preservatives; antimicrobial agents; fragrances, chelating agents (e.g., such as those described in U.S. Pat. No. 5,487,884 to Bisset et al.); sequestrants; vitamins (e.g., retinol); vitamin derivatives (e.g., tocopheryl acetate, panthenol); sunscreens; desquamation actives (e.g., such as those described in U.S. Pat. Nos. 5,681,852 and 5,684 to Bisset et al.); 5,652,228); anti-wrinkle / anti-atrophy actives (e.g., N-acetyl derivatives, thiols, hydroxy acids, phenols); antioxidants (e.g., ascorbic acid derivatives, tocopherols); skin soothing / skin healing agents (e.g., pantothenic acid derivatives, aloe vera, allantoin); skin lightening agents (e.g., kojic acid, arbutin, ascorbic acid derivatives); skin tanning agents (e.g., dihydroxyacetone); anti-acne medications; essential oils; sensates; pigments; colorants; pearlescent agents; interference pigments (e.g., such as Grant Liang No. 6,645,511 to Aronson et al., No. 6,759,376 to Zhang et al., No. 6,780,826 to Zhang et al., particles (e.g., talc, kaolin, mica, smectite clay, cellulose powder, polysiloxane, silica, carbonate, titanium dioxide, polyethylene beads), hydrophobically modified non-platelet particles (e.g., hydrophobically modified titanium dioxide and other materials described in commonly owned patent application entitled "Personal Care Compositions Containing Hydrophobically Modified Non-plateletparticle" filed by Taylor et al. on February 15, 2005 and published on August 17, 2006 as Publication No. 2006 / 0182699A), and mixtures thereof. The multi-phase personal care composition may comprise from about 0.1% to about 4%, by weight of the rinse-off personal care composition, of a hydrophobically modified titanium dioxide.Other such suitable examples of such skin actives are described in US Patent Application Serial No. 13 / 157,665.

[0198] Shaving care composition

[0199] The capsules of the present invention can be used in shaving compositions to provide one or more benefits, including freshness and / or cooling. The shaving compositions of the present invention can be in different forms. Non-limiting examples of such forms are: shaving creams, shaving gels, aerosol shaving gels, shaving soaps, aerosol shaving foams, liquids, pastes, Newtonian or non-Newtonian fluids, gels, and sols.

[0200] The shaving composition may include at least one beneficial agent encapsulated in the capsule at a level that promotes one or more beneficial effects upon direct use. In one embodiment of the present invention, the shaving composition includes from about 0.01% to about 15% of the at least one beneficial agent encapsulated in the capsule. In another embodiment, the shaving composition includes from about 0.05% to about 8% of the at least one beneficial agent encapsulated. In another embodiment, the shaving composition includes from about 0.1% to about 5% of the at least one beneficial agent encapsulated.

[0201] In addition to at least one capsule, the shaving composition of the present invention may also include a lathering surfactant, a carrier, adjuvant ingredients, and other additional ingredients.

[0202] Foaming surfactant

[0203] The shaving composition may contain one or more lathering surfactants and a carrier such as water at a total level of about 60% to about 99.99%. Lathering surfactants are defined herein as surfactants that produce foam or lather when combined with water and mechanically agitated. Preferably, these surfactants or combinations of surfactants should be mild, meaning that these surfactants provide adequate cleaning or detersive benefits but do not overly dry the skin or hair while still being able to produce lather.

[0204] A variety of foaming surfactants can be used herein, and include those selected from the following: anionic foaming surfactants, nonionic foaming surfactants, amphoteric foaming surfactants and mixtures thereof. Typically, foaming surfactants are quite water-soluble. When used in the composition, at least about 4% of the foaming surfactants have an HLB value greater than about 10. Examples of such surfactants can be found in U.S. Patent No. 5,624,666. Cationic surfactants can also be used as optional components, provided that they do not adversely affect the overall foaming properties of the desired foaming surfactant.

[0205] Concentrations of these surfactants range from about 10% to about 20%, alternatively from about 5% to about 25%, and alternatively from about 2% to about 60%, by weight of the composition.

[0206] Anionic foaming surfactants useful in the compositions of the present invention are disclosed in McCutcheon's Detergents and Emulsifiers, North American Edition (1986), published by Allured Publishing Corporation; McCutcheon's Functional Materials, North American Edition (1992); and U.S. Pat. No. 3,929,678. A variety of anionic foaming surfactants can be used herein. Non-limiting examples of anionic foaming surfactants include those selected from the group consisting of sarcosinates, sulfates, sulfonates, isethionates, taurates, phosphates, lactylates, glutamates, and mixtures thereof.

[0207] Other anionic materials useful herein are fatty acid soaps (i.e., alkali metal salts, e.g., sodium or potassium salts), monoalkyl, dialkyl, and trialkyl phosphates, typically having from about 8 to about 24 carbon atoms, preferably from about 10 to about 20 carbon atoms, corresponding to alkanoyl sarcosinates of the formula RCON(CH3)CH2CH2CO2M, wherein R is an alkyl or alkenyl group of from about 10 to about 20 carbon atoms, and M is a water-soluble cation, such as ammonium, sodium, potassium, and alkanolamines (e.g., triethanolamine). Also useful are taurates based on taurine (which is also known as 2-aminoethanesulfonic acid) and glutamates, particularly those having between C8 and C6. 16 Those between the carbon chains.

[0208] Non-limiting examples of preferred anionic lathering surfactants useful herein include those selected from the group consisting of sodium lauryl sulfate, ammonium lauryl sulfate, ammonium laureth sulfate, sodium laureth sulfate, sodium trideceth sulfate, ammonium cetyl sulfate, sodium cetyl sulfate, ammonium cocoyl isethionate, sodium lauroyl isethionate, sodium lauroyl lactylate, triethanolamine lauroyl lactylate, sodium caproyl lactylate, sodium lauroyl sarcosinate, sodium myristoyl sarcosinate, sodium cocoyl sarcosinate, sodium lauroyl methyl taurate, sodium cocoyl methyl taurate, sodium lauroyl glutamate, sodium myristoyl glutamate, and sodium cocoyl glutamate, and mixtures thereof.

[0209] Suitable amphoteric or zwitterionic detersive surfactants for use in the compositions herein include those known for use in hair care or other personal care cleansing. The concentration of such amphoteric detersive surfactants is from about 1% to about 10%, alternatively from about 0.5% to about 20%, by weight of the composition. Non-limiting examples of suitable zwitterionic or amphoteric surfactants are described in U.S. Pat. Nos. 5,104,646 and 5,106,609.

[0210] The nonionic foaming surfactants for use in the compositions of the present invention are disclosed in McCutcheon's Detergents and Emulsifiers, North American Edition (1986), published by Allured Publishing Corporation; and McCutcheon's Functional Materials, North American Edition (1992); the entire contents of both are incorporated herein by reference. Suitable nonionic foaming surfactants for use herein may include those selected from the group consisting of alkyl glucosides, alkyl polyglucosides, polyhydroxy fatty acid amides, alkoxylated fatty acid esters, foaming sucrose esters, amine oxides, and mixtures thereof.

[0211] Other examples of nonionic surfactants include amine oxides. Amine oxides correspond to the general formula R 1 R 2 R 3 NO, where R 1 An alkyl, alkenyl or monohydroxyalkyl radical containing from about 8 to about 18 carbon atoms, from 0 to about 10 ethylene oxide moieties, and from 0 to about 1 glyceryl moiety, and R 2 and R 3 Containing from about 1 to about 3 carbon atoms and 0 to about 1 hydroxyl groups, for example, methyl, ethyl, propyl, hydroxyethyl or hydroxypropyl free radicals. Examples of amine oxides suitable for use in the present invention include dimethyl-dodecylamine oxide, oleyl di(2-hydroxyethyl)amine oxide, dimethyloctylamine oxide, dimethyl-decylamine oxide, dimethyl-tetradecylamine oxide, 3,6,9-trioxoheptadecyldiethylamine oxide, di(2-hydroxyethyl)-tetradecylamine oxide, 2-dodecyloxyethyldimethylamine oxide, 3-dodecyloxy-2-hydroxypropyldi(3-hydroxypropyl)amine oxide, dimethylhexadecylamine oxide.

[0212] The foaming surfactant for use can be one or more of the following items, wherein the anionic foaming surfactant is selected from: ammonium lauroyl sarcosinate, sodium tridecyl polyoxyethylene ether sulfate, sodium lauroyl sarcosinate, sodium myristoyl sarcosinate, ammonium lauryl polyoxyethylene ether sulfate, sodium lauryl polyoxyethylene ether sulfate, ammonium lauryl sulfate, sodium lauryl sulfate, ammonium cocoyl isethionate, sodium cocoyl isethionate, sodium lauroyl isethionate, sodium cetyl sulfate, sodium lauroyl lactylate, triethanolamine lauroyl lactylate and mixtures thereof; wherein the nonionic foaming surfactant is selected from: laurylamine oxide, coconut amine oxide, decyl polyglucose, lauryl polyglucose, sucrose cocoate, C 12-14Gluconamide, sucrose laurate and mixtures thereof; and wherein the amphoteric foaming surfactant is selected from: disodium lauroamphodiacetate, sodium lauroamphoacetate, hexadecyl dimethyl betaine, cocoamidopropyl betaine, cocoamidopropyl hydroxysulfonate and mixtures thereof.

[0213] Suitable foaming surfactants are polyglycerol fatty acid esters. In one embodiment, the polyglycerol fatty acid ester surfactant has the following formula:

[0214]

[0215] wherein n is 1 to 10, and X is a hydrogen atom or a 12-22 A long chain acyl group of a fatty acid or an N-fatty acyl-neutral amino acid, provided that at least one X is a long chain acyl group and no more than three X are long chain acyl groups. In one embodiment, the polyglyceryl fatty acid ester surfactant is selected from the group consisting of polyglyceryl-10 oleate, polyglyceryl-6 stearate, polyglyceryl-10 stearate, polyglyceryl-8 dipalmitate, polyglyceryl-10 dipalmitate, polyglyceryl-10 behenate, and polyglyceryl-12 trilaurate.

[0216] Carrier

[0217] The shaving composition of the present invention may further comprise a carrier. In one embodiment, the carrier comprises water. The carrier is preferably dermatologically acceptable, meaning that the carrier is suitable for topical application to keratinous tissue, has good aesthetic properties, is compatible with the active substances and any other components of the present invention, and does not raise any safety or toxicity issues. In one embodiment, the shaving composition comprises from about 50% to about 99.99%, preferably from about 60% to about 99.9%, more preferably from about 70% to about 98%, and even more preferably from about 80% to about 95% of a carrier by weight of the composition.

[0218] Auxiliary ingredients

[0219] In an embodiment, the shaving composition may include at least one lubricant selected from the group consisting of: lubricating water-soluble polymers; water-insoluble particles, hydrogel-forming polymers, and mixtures thereof.

[0220] Lubricating water-soluble polymers generally have a molecular weight greater than between about 300,000 Daltons and 15,000,000 Daltons, preferably greater than about one million Daltons, and include a sufficient number of hydrophilic moieties or substituents on the polymer chain to render the polymer water-soluble. The polymer may be a homopolymer, a copolymer, or a terpolymer. Examples of suitable lubricating water-soluble polymers include polyethylene oxide, polyvinyl pyrrolidone, and polyacrylamide. Preferred lubricating water-soluble polymers include polyethylene oxide, and more specifically, polyethylene oxide having a molecular weight of about 0.5 to about 5 million Daltons. Examples of suitable polyethylene oxides: PEG-23M, PEG-45M, and PEG-90M. The content of the lubricating water-soluble polymer may be from about 0.005% to about 3%, preferably from about 0.01% to about 1%, by weight.

[0221] The water-insoluble particles may include inorganic particles or organic polymer particles. Examples of inorganic particles include titanium dioxide, silicon dioxide, silicates and glass beads, preferably glass beads. Examples of organic polymer particles include polytetrafluoroethylene particles, polyethylene particles, polypropylene particles, polyurethane particles, polyamide particles, or a mixture of two or more such particles.

[0222] Hydrogel-forming polymers are highly hydrophilic polymers that form ordered three-dimensional domains on the order of nanometers in water. Hydrogel-forming polymers generally have a molecular weight greater than about one million Daltons (although lower molecular weights are possible) and are typically at least partially or lightly cross-linked and may be at least partially water-insoluble, but also include a sufficient number of hydrophilic moieties to enable the polymer to capture or bind large amounts of water within the polymer matrix and thereby form three-dimensional domains. Typically, the hydrogel-forming polymer will be included in the shaving composition in an amount of about 0.0005% to about 3%, or about 0.001% to about 0.5%, or about 0.002% to about 0.1% by weight.

[0223] Examples of suitable hydrogel-forming polymers include: polyacrylic acid or polymethacrylic acid partially esterified with a polyol; hydrophilic polyurethanes; lightly cross-linked polyethylene oxide; lightly cross-linked polyvinyl alcohol; lightly cross-linked polyacrylamide; hydrophobically modified hydroxyalkyl cellulose; hydroxyethyl methacrylate; and cross-linked hyaluronic acid. Preferred hydrogel-forming polymers include polyacrylic acid partially esterified with glycerol (e.g., about 40% to 60%, preferably about 50% esterified). Such polymers include glyceryl acrylate / acrylic acid copolymers. Glyceryl acrylate / acrylic acid copolymers are highly hydrophilic, have a molecular weight greater than 1 million Daltons and typically include a polyacrylic acid backbone partially esterified with glycerol (typically about 50% esterified). It is believed that glyceryl acrylate / acrylic acid copolymers form inclusion complexes that retain water, which provide lubricity and moisturizing properties to the skin when released. It has been found that shaving gel compositions containing glyceryl acrylate / acrylic acid copolymers have improved gel structure and reduced friction coefficient (i.e., increased lubricity). See, e.g., US2006 / 00257349 10.

[0224] As used herein, the term "water-dispersible" means that a substance is substantially dispersible or soluble in water. Water-dispersible surfactants are preferably surfactants capable of forming foam, such as one or more of the optional foaming surfactants described in Section 5 below (including but not limited to soaps, discontinuous soaps, detergents, anionic surfactants, nonionic surfactants, or mixtures of one or more of these).

[0225] 1. Polar solvents

[0226] In an embodiment, the carrier includes a polar solvent. The content of the polar solvent may be from about 1% to about 20% or from about 5% to about 10%. The polar solvents that may be used herein include polyols, such as 3-butylene glycol, propylene glycol, ethylene glycol, diethylene glycol, sorbitol and other sugars in liquid form at ambient temperature, glycerol, sorbitol, propylene glycol, butylene glycol, pentanediol, hexylene glycol, ethoxylated glucose, 1,2-hexanediol, hexanetriol, dipropylene glycol, erythritol, trehalose, diglycerol, xylitol, maltitol, maltose, glucose, fructose, sodium chondroitin sulfate, sodium hyaluronate, sodium adenosine phosphate, sodium lactate, pyrrolidone carbonate, glucosamine, cyclodextrin and mixtures thereof. It may also be preferred to use polyols such as those containing 2 to about 6 carbon atoms and 2 to about 6 hydroxyl groups (e.g., 1,3-propylene glycol, ethylene glycol, glycerol and 1,2-propylene glycol). Most preferred are butanediol, pentanediol or hexanediol, and mixtures thereof.

[0227] Without wishing to be bound by theory, it is believed that the addition of one or more polar solvents allows the viscosity of the shaving composition to be reduced and improves its clarity while maintaining good lubricity.

[0228] The shaving composition of the present invention may include a salicylic acid compound, an ester thereof, a salt thereof, or a combination thereof. In the composition of the present invention, the salicylic acid compound preferably includes from about 0.1% to about 5%, preferably from about 0.2% to about 2%, and more preferably from about 0.5% to about 2% salicylic acid by weight of the composition.

[0229] The shaving compositions of the present invention may contain a variety of other ingredients conventionally used in a given product type, provided that they do not unacceptably alter the benefits of the present invention. These ingredients should be included in amounts that are safe and effective for the shaving composition to be applied to the skin.

[0230] The CTFA Cosmetic Ingredient Handbook, Second Edition (1992) describes a variety of non-limiting cosmetic and pharmaceutical ingredients commonly used in the skin care field that are suitable for use in the compositions of the present invention. Examples of these ingredient categories include: abrasives, absorbents, aesthetic components such as fragrances, pigments, colorants / colorants, essential oils, skin sensitizers, astringents, etc. (e.g., clove oil, menthol, camphor, eucalyptus oil, eugenol, menthyl lactate, witch hazel distillate), anti-acne agents, anti-caking agents, defoaming agents, antimicrobial agents (e.g., iodopropyl butylcarbamate), antioxidants, binders, biological additives, buffers, extenders, chelating agents, chemical additives, colorants, cosmetics Astringents, cosmetic insecticides, denaturants, pharmaceutical astringents, topical analgesics, fatty alcohols and fatty acids, film formers or film-forming materials such as polymers that contribute to the film-forming properties and substantivity of the composition (e.g., copolymers of eicosene and vinyl pyrrolidone), sunscreens, pH adjusters, propellants, reducing agents, sequestrants, skin whitening and lightening agents, skin conditioning agents, skin soothing and / or healing agents and derivatives, skin treatment agents, thickeners and vitamins, and their derivatives.

[0231] Additional non-limiting examples of additional suitable skin treatment actives include those in Section I of US 2003 / 0082219 (i.e., hexamidine, zinc oxide); Section D of US 5,665,339 (i.e., cooling agents, skin conditioning agents, sunscreens and pigments, and medicaments); and US 2005 / 0019356 (i.e., desquamation actives, anti-acne actives, chelating agents, flavonoids, antimicrobial actives, and antifungal actives). Other useful optional ingredients include: anti-wrinkle actives and / or anti-atrophy actives; antioxidants and / or Racial scavengers; anti-inflammatory agents; anti-cellulite agents; tanning actives; skin lightening agents; sunscreen actives; water-soluble vitamins; particles; and combinations thereof.

[0232] The shaving composition of the present invention is a non-aerosol composition.In one embodiment, the shaving composition is free or substantially free of volatile post-foaming agents.

[0233] a. A skin conditioning agent, more preferably a conditioning agent as defined previously

[0234] b. Thickeners (including thickeners and gelling agents)

[0235] The compositions of the present invention may contain one or more thickeners, preferably from about 0.05% to about 10%, more preferably from about 0.1% to about 5%, and even more preferably from about 0.25% to about 4%, by weight of the composition. Non-limiting classes of thickeners include those selected from the following: carboxylic acid polymers (crosslinked compounds comprising one or more monomers derived from acrylic acid, substituted acrylic acid, and salts and esters of these acrylic acid and substituted acrylic acid, wherein the crosslinking agent contains two or more carbon-carbon double bonds and is derived from a polyol); crosslinked polyacrylate polymers (including cationic and nonionic polymers, such as U.S. Pat. Nos. 5,100,660, 4,849,484, 4,835,206, 4,628,078, 4,599,379 and EP 228,868); polysulfonic acids (such as copolymers of acryloyldimethyl taurate and vinyl pyrrolidone) and hydrophobically modified polysulfonic acids (such as cross-linked polymers of acryloyldimethyl taurate and beheneth-25 methacrylate); polyacrylamide polymers (such as nonionic polyacrylamide polymers, including substituted branched or unbranched polymers such as polyacrylamide and isoparaffin and laureth-7, and multi-block copolymers of acrylamide and substituted acrylamide with acrylic acid and substituted acrylic acid); polysaccharides (non-limiting examples of polysaccharide gelling agents include those selected from the group consisting of cellulose, carboxymethyl hydroxyethyl cellulose, cellulose acetate propionate carboxylate, hydroxyethyl cellulose, hydroxyethyl ethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, methyl hydroxyethyl cellulose, microcrystalline cellulose, sodium cellulose sulfate, and mixtures thereof); gums (i.e., gums such as acacia, agar, algin, alginic acid, ammonium alginate, pullulan, Calcium alginate, calcium carrageenan, carnitine, carrageenan, dextrin, gelatin, gellan gum, guar gum, guar hydroxypropyltrimonium chloride, hectorite, hyaluronic acid, hydrated silica, hydroxypropyl chitosan, hydroxypropyl guar gum, karaya gum, seaweed, locust bean gum, natto gum, potassium alginate, potassium carrageenan, propylene glycol alginate, sclerotium gum, sodium carboxymethyl dextran, sodium carrageenan, tragacanth gum, xanthan gum and mixtures thereof); and crystalline hydroxy-containing fatty acids, fats Esters or fatty waxes (such as the microfibrous bacterial cellulose structurants described in U.S. Pat. Nos. 6,967,027 to Heux et al., 5,207,826 to Westland et al., 4,487,634 to Turbak et al., 4,373,702 to Turbak et al., and 4,863,565 to Johnson et al., U.S. Pat. Pub. No. 2007 / 0027108 to Yang et al.).

[0236] pH

[0237] The shaving compositions of the present invention preferably have a pH of less than about 9, more preferably less than about 7. In one embodiment, the composition has a pH of less than about 5 or less than about 4. In a preferred embodiment, the composition has a pH of about 2.5 to about 4.5. Suitable lathering surfactants for use at pH levels below about 4 may be selected from the group consisting of alkyl sulfonates, pareth sulfonates, sulfobetaines, alkylhydroxysulfobetaines, alkyl glucosides, and mixtures thereof.

[0238] capsule

[0239] The liquid hair care, personal care, and shave care compositions of the present disclosure also comprise a population of capsules.As described in more detail below, a capsule may include a core surrounded by a substantially inorganic shell.

[0240] The capsules may be present in the composition in an amount of about 0.05% to about 20%, or about 0.05% to about 10%, or about 0.1% to about 5%, or about 0.2% to about 2%, by weight of the composition. The composition may include a sufficient amount of the capsules to provide the composition with about 0.05% to about 10%, or about 0.1% to about 5%, or about 0.1% to about 2% of the fragrance raw materials by weight of the composition. When discussing the amount or weight percentage of the capsules herein, it means the sum of the shell material and the core material.

[0241] The capsules may have an average shell thickness of about 10 nm to about 10,000 nm, preferably about 170 nm to about 1000 nm, more preferably about 300 nm to about 500 nm.

[0242] In embodiments, the capsules may have an average volume weighted capsule diameter of about 0.1 micrometer to 300 micrometers, about 0.1 micrometer to about 200 micrometers, about 1 micrometer to about 200 micrometers, about 10 micrometers to about 200 micrometers, about 10 micrometers to about 50 micrometers. It has been advantageously found that large capsules (e.g., an average diameter of about 10 μm or greater) can be provided according to embodiments herein without sacrificing overall capsule stability and / or while maintaining good burst strength.

[0243] It has been surprisingly found that, in addition to the inorganic shell, the volume core-shell ratio can play an important role in ensuring the physical integrity of the capsule. Shells that are too thin compared to the overall size of the capsule (core: shell ratio>98:2) often lack self-integrity. On the other hand, very thick shells tend to have higher shell permeability in a surfactant-rich matrix relative to the capsule diameter (core: shell ratio<80:20). Although one may intuitively believe that thick shells can lead to lower shell permeability (because this parameter affects the average diffusion path of the active substance through the shell), it has been surprisingly found that the capsules of the present invention with shells having a thickness above a threshold have higher shell permeability. It is believed that this upper threshold depends in part on the capsule diameter. The volume core-shell ratio is measured according to the method provided in the "Test Methods" section below.

[0244] The capsules may have a volume core-shell ratio of 50:50 to 99:1, preferably 60:40 to 99:1, preferably 70:30 to 98:2, more preferably 80:20 to 96:4.

[0245] It may be desirable to have a particular combination of these capsule properties. For example, the capsule may have a volume core-shell ratio of about 99:1 to about 50:50; and have an average volume weighted capsule diameter of about 0.1 μm to about 200 μm and an average shell thickness of about 10 nm to about 10,000 nm. The capsule may have a volume core-shell ratio of about 99:1 to about 50:50; and have an average volume weighted capsule diameter of about 10 μm to about 200 μm and an average shell thickness of about 170 nm to about 10,000 nm. The capsule may have a volume core-shell ratio of about 98:2 to about 70:30; and have an average volume weighted capsule diameter of about 10 μm to about 100 μm and an average shell thickness of about 300 nm to about 1000 nm.

[0246] In certain embodiments, the average volume weighted diameter of the capsule is between 1 micron and 200 microns, preferably between 1 micron and 10 microns, even more preferably between 2 microns and 8 microns. In another embodiment, the shell thickness is between 1 nm and 10000 nm, 1 nm to 1000 nm, 10 nm-200 nm. In another embodiment, the capsule has an average volume weighted diameter between 1 micron and 10 microns and a shell thickness between 1 nm and 200 nm. It has been found that capsules with an average volume weighted diameter between 1 micron and 10 microns and a shell thickness between 1 nm and 200 nm have higher rupture strength.

[0247] Without wishing to be bound by theory, it is believed that higher burst strength provides better durability during the washing process which may cause mechanically weak capsules to rupture prematurely due to mechanical constraints in the washing machine.

[0248] Capsules with an average volume weighted diameter between 1 micron and 10 microns and a shell thickness between 10 nm and 200 nm, when prepared with a specifically selected silica precursor used, provide only resistance to mechanical constraints. In some embodiments, the precursor has a molecular weight between 2 kDa and 5 kDa, even more preferably between 2.5 kDa and 4 kDa. In addition, the concentration of the precursor needs to be carefully selected, wherein the concentration is between 20% and 60% by weight of the oil phase used during encapsulation, preferably between 40% and 60% by weight.

[0249] Without being bound by theory, it is believed that higher molecular weight precursors have a much slower migration time from the oil phase to the water phase. The slower migration time is believed to be caused by a combination of the following three phenomena: diffusion, distribution, and reaction kinetics. This phenomenon is important in the case of small size capsules, because the total surface area between the oil and water in the system increases as the capsule diameter decreases. Higher surface area leads to higher migration of the precursor from the oil phase to the water phase, which in turn reduces the polymerization yield at the interface. Therefore, higher molecular weight precursors may be needed to mitigate the effects of the increased surface area and obtain capsules according to the present invention.

[0250] The method according to the present disclosure can produce capsules with low coefficient of variation of capsule diameter. Control of the capsule size distribution can beneficially allow the population to have improved and more uniform rupture strength. The capsule population can have a coefficient of variation of capsule diameter of 40% or less, preferably 30% or less, more preferably 20% or less.

[0251] In order for capsules containing core materials to be functional and cost-effective in consumer product applications (such as liquid hair care, personal care and shaving care compositions), they should: i) resist diffusion of the core during the shelf life of the liquid product (e.g., low leakage or permeability); ii) have the ability to deposit on target surfaces (e.g., skin and hair) during application; and iii) be able to release the core material by mechanical shell rupture at the appropriate time and place to provide the desired benefit to the end consumer.

[0252] The capsules described herein may have an average rupture strength of 0.1 MPa to 10 MPa, preferably 0.25 MPa to 5 MPa, more preferably 0.25 MPa to 3 MPa. Completely inorganic capsules traditionally have poor rupture strength, while for the capsules described herein, the rupture strength of the capsules may be greater than 0.25 MPa, thereby providing improved stability and triggered release of the beneficial agent at a specified amount of rupture stress.

[0253] The core is oil-based. The core may be liquid at the temperature at which it is used to formulate the product. The core may be liquid at or near room temperature.

[0254] The core preferably includes a fragrance raw material. Based on the total weight of the core, the core may include about 1 wt % to 100 wt % of fragrance. Preferably, the core may include about 50 wt % to 100 wt % of fragrance based on the total weight of the core, more preferably 80 wt % to 100 wt % of fragrance based on the total weight of the core. Typically, in order to improve delivery efficiency, higher levels of fragrance are preferred.

[0255] The fragrance raw materials may comprise one or more, preferably two or more, fragrance raw materials. As used herein, the term "fragrance raw materials" (or "PRMs") refers to compounds having a molecular weight of at least about 100 g / mol, and which can be used alone or with other fragrance raw materials to impart odor, aroma, flavor or fragrance. Typical PRMs include alcohols, ketones, aldehydes, esters, ethers, nitrites and olefins, such as terpenes.

[0256] PRMs can be characterized by their boiling point (BP) measured at atmospheric pressure (760 mm Hg), and their octanol / water partition coefficient (P), which can be described in terms of logP, as determined according to the test methods described in the Test Methods section. Based on these characteristics, PRMs can be classified as Quadrant I, Quadrant II, Quadrant III, or Quadrant IV fragrances, as described in detail below. A fragrance having multiple PRMs from different quadrants may be desirable, for example, to provide fragrance benefits at different contact points during normal use.

[0257] Perfume raw materials with a boiling point BP below about 250°C and a logP of less than about 3 are referred to as Quadrant I perfume raw materials. Quadrant I perfume raw materials are preferably limited to less than 30% of the perfume composition. Perfume raw materials with a BP above about 250°C and a logP greater than about 3 are referred to as Quadrant IV perfume raw materials, perfume raw materials with a BP above about 250°C and a logP less than about 3 are referred to as Quadrant II perfume raw materials, and perfume raw materials with a BP below about 250°C and a logP greater than about 3 are referred to as Quadrant III perfume raw materials.

[0258] Preferably, the capsule contains a fragrance. Preferably, the fragrance of the capsule contains a mixture of at least 3, or even at least 5, or at least 7 fragrance raw materials. The fragrance of the capsule may contain at least 10 or at least 15 fragrance raw materials. A mixture of fragrance raw materials may, for example, provide more complex and desired aesthetics at multiple contact points, and / or better fragrance performance or persistence. However, it may be desirable to limit the number of fragrance raw materials in the fragrance to reduce or limit formulation complexity and / or cost.

[0259] The fragrance may include at least one fragrance raw material of natural origin. Such components may be desirable for sustainability / environmental reasons. The fragrance raw materials of natural origin may include natural extracts or essences, which may include a mixture of PRMs. Such natural extracts or essential oils may include orange oil, lemon oil, rose extract, lavender, musk, patchouli, balsam essence, sandalwood oil, pine oil, cedar, etc.

[0260] In addition to the perfume raw materials, the core may also include a pro-perfume, which may help improve the persistence of the freshness benefit. The pro-perfume may include a non-volatile material that is released or converted into a perfume material due to, for example, simple hydrolysis, or may be a pro-perfume triggered by a pH change (e.g., triggered by a drop in pH), or may be an enzyme-released pro-perfume, or a light-triggered pro-perfume. Depending on the pro-perfume selected, the pro-perfume may exhibit different release rates.

[0261] The core of the encapsulate of the present disclosure may include a core modifier, such as a distribution modifier and / or a density modifier. In addition to the fragrance, the core may also include greater than 0% to 80%, preferably greater than 0% to 50%, more preferably greater than 0% to 30% of the core modifier based on the total core weight. The distribution modifier may include a material selected from the group consisting of vegetable oils, modified vegetable oils, C4-C 24 Monoesters, diesters and triesters of fatty acids, isopropyl myristate, lauryl benzophenone, lauryl laurate, methyl behenate, methyl laurate, methyl palmitate, methyl stearate and mixtures thereof. The distribution modifier may preferably comprise isopropyl myristate or consist of isopropyl myristate. The modified vegetable oil may be esterified and / or brominated. The modified vegetable oil may preferably comprise castor oil and / or soybean oil.

[0262] The shell may comprise between 90% and 100%, preferably between 95% and 100%, more preferably between 99% and 100% of inorganic material by weight of the shell. Preferably, the inorganic material in the shell comprises a material selected from metal oxides, semi-metal oxides, metals, minerals or mixtures thereof. Preferably, the inorganic material in the shell comprises a material selected from SiO2, TiO2, Al2O3, ZrO2, ZnO2, CaCO3, Ca2SiO4, Fe2O3, Fe3O4, clay, gold, silver, iron, nickel, copper or mixtures thereof. More preferably, the inorganic material in the shell comprises a material selected from SiO2, TiO2, Al2O3, CaCO3 or mixtures thereof, most preferably SiO2.

[0263] The shell may include a first shell member. The shell may preferably include a second shell member surrounding the first shell member. The first shell member may include a condensation layer formed by a condensation product of a precursor. As described in detail below, the precursor may include one or more precursor compounds. The first shell member may include a nanoparticle layer. The second shell member may include an inorganic material.

[0264] The inorganic shell may comprise a first shell component, the first shell component comprising a condensation layer surrounding the core, and may also comprise a nanoparticle layer surrounding the condensation layer. The inorganic shell may also comprise a second shell component surrounding the first shell component. The first shell component comprises an inorganic material, preferably a metal / semi-metal oxide, more preferably SiO2, TiO2 and Al2O3 or a mixture thereof, even more preferably SiO2. The second shell component comprises an inorganic material, preferably a material selected from the group of metal / semi-metal oxides, metals and minerals, preferably a material selected from the list of the following: SiO2, TiO2, Al2O3, ZrO2, ZnO2, CaCO3, Ca2SiO4, Fe2O3, Fe3O4, clay, gold, silver, iron, nickel and copper, or a mixture thereof, even more preferably selected from SiO2 and CaCO3 or a mixture thereof. Preferably, the second shell component material has the same type of chemical property as the first shell component, so that chemical compatibility is maximized.

[0265] The first shell component may include a condensation layer surrounding the core. The condensation layer may be a condensation product of one or more precursors. The one or more precursors may include at least one compound from the group consisting of formula (I), formula (II), or a mixture thereof, wherein formula (I) is (M v O z Y n ) w , and wherein the formula (II) is (M v O z Y n R 1 p ) w It may be preferred that the precursor comprises only formula (I) and no compound according to formula (II), for example in order to reduce the organic content of the capsule shell (ie, no R 1 Formulae (I) and (II) are described in more detail below.

[0266] One or more precursors may have formula (I):

[0267] (M v O z Y n ) w (Formula I),

[0268] wherein M is one or more of silicon, titanium and aluminum, v is the valence number of M and is 3 or 4, z is 0.5 to 1.6, preferably 0.5 to 1.5, each Y is independently selected from -OH, -OR 2 、-NH2、-NHR 2 、-N(R 2 )2, where R 2 For C1 to C 20 Alkyl, C1 to C 20 Alkylene, C6 to C 22 aryl, or a 5- to 12-membered heteroaryl group containing 1 to 3 ring heteroatoms selected from O, N and S, R 3 H, C1 to C 20 Alkyl, C1 to C 20 Alkylene, C6 to C 22 Aryl, or a 5- to 12-membered heteroaryl group containing 1 to 3 ring heteroatoms selected from O, N and S, n is 0.7 to (v-1), and w is 2 to 2000.

[0269] One or more precursors may have formula (I) wherein M is silicon. Possibly, Y is -OR 2 It is possible that n is 1 to 3. It may be preferred that Y is -OR 2 and n is 1 to 3. It is possible that n is at least 2 and one or more of Y is -OR 2 , and one or more of Y is -OH.

[0270] R 2 Can be C1 to C 20 Alkyl. 2 Can be C6 to C 22 Aryl. 2 It may be one or more of a C1 alkyl group, a C2 alkyl group, a C3 alkyl group, a C4 alkyl group, a C5 alkyl group, a C6 alkyl group, a C7 alkyl group and a C8 alkyl group. 2 It can be a C1 alkyl group. 2 It can be a C2 alkyl group. 2 It can be a C3 alkyl group. 2 It may be a C4 alkyl group.

[0271] Possibly, z is from 0.5 to 1.3, or from 0.5 to 1.1, from 0.5 to 0.9, or from 0.7 to 1.5, or from 0.9 to 1.3, or from 0.7 to 1.3.

[0272] It may be preferred that M is silicon, v is 4, and each Y is -OR 2 , n is 2 and / or 3, and each R 2 It is a C2 alkyl group.

[0273] The precursor may include polyalkoxysilane (PAOS). The precursor may include polyalkoxysilane (PAOS) ​​synthesized by a hydrolysis process.

[0274] The precursor may alternatively or additionally comprise one or more of the compounds of formula (II):

[0275] (M v O z Y n R 1 p ) w (Formula II),

[0276] wherein M is one or more of silicon, titanium and aluminum, v is the valence number of M and is 3 or 4, z is 0.5 to 1.6, preferably 0.5 to 1.5, each Y is independently selected from -OH, -OR 2 、-NH2、-NHR 2 、-N(R 2 )2, where R 2 Select from C1 to C 20 Alkyl, C1 to C 20 Alkylene, C6 to C 22 aryl, or a 5- to 12-membered heteroaryl group containing 1 to 3 ring heteroatoms selected from O, N and S, R 3 H, C1 to C 20 Alkyl, C1 to C 20 Alkylene, C6 to C 22 aryl, or a 5- to 12-membered heteroaryl group containing 1 to 3 ring heteroatoms selected from O, N and S; n is 0 to (v-1); each R 1 Independently selected from: C1 to C 30 Alkyl; C1 to C 30 Alkylene; C1 to C2 substituted by a member selected from halogen, -OCF3, -NO2, -CN, -NC, -OH, -OCN, -NCO, alkoxy, epoxy, amino, mercapto, acryloyl, -C(O)OH, -C(O)O-alkyl, -C(O)O-aryl, -C(O)O-heteroaryl, and mixtures thereof 30 Alkyl; and C1 to C2 substituted by a member selected from halogen, -OCF3, -NO2, -CN, -NC, -OH, -OCN, -NCO, alkoxy, epoxy, amino, mercapto, acryloyl, -C(O)OH, -C(O)O-alkyl, -C(O)O-aryl and -C(O)O-heteroaryl. 30 Alkylene; and p is a number greater than zero and up to pmax, wherein pmax=60 / [9*Mw(R 1 )+8], where Mw(R 1 ) is R 1The molecular weight of the group, and wherein w is 2 to 2000.

[0277] R 1 It can be a C1 to C2 substituted group which is independently selected from halogen, -OCF3, -NO2, -CN, -NC, -OH, -OCN, -NCO, alkoxy, epoxy, amino, mercapto, acryloyl, CO2H (i.e., C(O)OH), -C(O)O-alkyl, -C(O)O-aryl and -C(O)O-heteroaryl. 30 Alkyl. 1 It can be a C1 to C2 substituted group which is independently selected from halogen, -OCF3, -NO2, -CN, -NC, -OH, -OCN, -NCO, alkoxy, epoxy, amino, mercapto, acryloyl, CO2H, -C(O)O-alkyl, -C(O)O-aryl and -C(O)O-heteroaryl. 30 Alkylene.

[0278] As mentioned above, in order to reduce or even eliminate the organic content in the first shell part, it may be preferred to reduce or even eliminate the presence of compounds according to formula (II) having R1 groups. The precursor, condensation layer, first shell part and / or shell may be free of compounds according to formula (II).

[0279] The precursors of formula (I) and / or (II) may be characterized by one or more physical properties, i.e., molecular weight (Mw), degree of branching (DB), and polydispersity index (PDI) of molecular weight distribution. It is believed that the selection of a specific Mw and / or DB can be used to obtain capsules that maintain their mechanical integrity after drying on the surface and have low shell permeability in a surfactant-based matrix. The precursors of formula (I) and (II) may be characterized by having a DB between 0 and 0.6, preferably between 0.1 and 0.5, more preferably between 0.19 and 0.4, and / or a Mw between 600Da and 100000Da, preferably between 700Da and 60000Da, more preferably between 1000Da and 30000Da. This feature provides useful properties of the precursor to obtain capsules of the present invention. The precursors of formula (I) and / or (II) may have a PDI between 1 and 50.

[0280] The condensation layer comprising a metal / semi-metal oxide may be formed from the condensation product of a precursor comprising at least one compound of formula (I) and / or at least one compound of formula (II), optionally in combination with one or more monomeric precursors of metal / semi-metal oxides, wherein the metal / semi-metal oxide comprises TiO2, Al2O3 and SiO2, preferably SiO2. The monomeric precursor of the metal / semi-metal oxide may comprise a compound of formula M(Y) V-n R nwherein M, Y and R are as defined in formula (II), and n may be an integer between 0 and 3. The monomeric precursor of the metal / semi-metal oxide may preferably be in the form where M is silicon, wherein the compound has the general formula Si(Y): 4-n R n , wherein Y and R are as defined for formula (II) and n may be an integer between 0 and 3. Examples of such monomers are TEOS (tetraethoxyorthosilicate), TMOS (tetramethoxyorthosilicate), TBOS (tetrabutoxyorthosilicate), triethoxymethylsilane (TEMS), diethoxy-dimethylsilane (DEDMS), trimethylethoxysilane (TMES) and tetraacetoxysilane (TAcS). These are not intended to limit the scope of monomers that may be used, and it will be apparent to those skilled in the art what suitable monomers may be used in combination herein.

[0281] The first shell component may include an optional nanoparticle layer. The nanoparticle layer comprises nanoparticles. The nanoparticles of the nanoparticle layer may be one or more of SiO2, TiO2, Al2O3, ZrO2, ZnO2, CaCO3, clay, silver, gold and copper. Preferably, the nanoparticle layer may comprise SiO2 nanoparticles.

[0282] The nanoparticles may have an average diameter between 1 nm and 500 nm, preferably between 50 nm and 400 nm.

[0283] The pore size of the capsule can be adjusted by changing the shape of the nanoparticle and / or by using a combination of different nanoparticle sizes. For example, non-spherical irregular nanoparticles can be used because they can have improved accumulation when forming a nanoparticle layer, and it is believed that this can produce a more dense shell structure. When limited permeability is required, this can be advantageous. The nanoparticle used can have a more regular shape, such as a sphere. Any imagined nanoparticle shape can be used herein.

[0284] The nanoparticles may be substantially free of hydrophobic modifications. The nanoparticles may be substantially free of organic compound modifications. The nanoparticles may include organic compound modifications. The nanoparticles may be hydrophilic.

[0285] The nanoparticles may include surface modifications such as, but not limited to, linear or branched C1 to C 20 Alkyl groups, surface amino groups, surface methacryloyl groups, surface halogens or surface thiols. These surface modifications allow the nanoparticle surface to have covalently bound organic molecules thereon. When inorganic nanoparticles are disclosed in this document, this means including any of the above surface modifications or not including the above surface modifications without explicit indication.

[0286] The capsules of the present disclosure may be defined as comprising a substantially inorganic shell comprising a first shell member and a second shell member. Substantially inorganic means that the first shell member may contain up to 10 wt% or up to 5 wt% organic content, preferably up to 1 wt% organic content, as defined later in the organic content calculation. It may be preferred that the first shell member, the second shell member, or both contain no more than about 5 wt%, preferably no more than about 2 wt%, more preferably about 0 wt% organic content based on the weight of the first or shell member.

[0287] While the first shell member can be used to construct a mechanically robust scaffold or skeleton, it can also provide low shell permeability in liquid products containing surfactants (such as laundry detergents, shower gels, cleaning agents, etc.) (see Surfactants in Consumer Products, J. Falbe, Springer-Verlag). The second shell member can greatly reduce the shell permeability, which improves the capsule impermeability in a surfactant-based matrix. The second shell member can also greatly improve the capsule mechanical properties, such as capsule rupture force and rupture strength. Without being bound by theory, it is believed that the second shell member contributes to the densification of the entire shell by depositing the precursor in the holes retained in the first shell member. The second shell member also adds an additional inorganic layer to the surface of the capsule. These improved shell permeability and mechanical properties provided by the second shell member only appear when used in combination with the first shell member as defined in the present invention.

[0288] Capsules of the present disclosure can be formed by first mixing hydrophobic material with any one of the precursors of the condensation layer as defined above, thereby forming an oil phase, wherein the oil phase can comprise an oil base and / or an oil-soluble precursor. The precursor / hydrophobic material mixture is then used as the dispersed phase combined with an aqueous phase, wherein once via methods well known to those skilled in the art two phases are mixed and homogenized just to form an O / W (oil-in-water) emulsion. Nanoparticles can be present in aqueous phase and / or the oil phase, and have nothing to do with the desired emulsion type. The oil phase can comprise the precursors of an oil-based core modifier and / or an oil-based benefit agent and a condensation layer. Suitable core materials for the oil phase have been described herein before.

[0289] Once the emulsion is formed, the following steps can be performed:

[0290] (a) Nanoparticles migrate to the oil / water interface, forming a nanoparticle layer.

[0291] (b) The precursor of the condensation layer comprising the metal / semi-metal oxide precursor will begin to undergo a hydrolysis / condensation reaction with water at the oil / water interface, thereby forming a condensation layer surrounded by the nanoparticle layer.

[0292] The precursor of the condensation layer may further react with the nanoparticles of the nanoparticle layer.

[0293] The condensation layer-forming precursor may be present in an amount between 1 wt% and 50 wt%, preferably between 10 wt% and 40 wt%, based on the total weight of the oil phase.

[0294] The oil phase composition may comprise any compound as defined above in the core section. Prior to emulsification, the oil phase may comprise from 10 wt % to about 99 wt % of the benefit agent.

[0295] In the method for preparing capsules according to the present disclosure, the oil phase can be a dispersed phase, and the continuous aqueous (or water) phase can include water, an acid or a base and nanoparticles. At least when the oil phase and the aqueous phase are mixed together, the aqueous phase can have a pH between 1 and 11, preferably between 1 and 7. The acid can be a strong acid. The strong acid can include one or more of HCl, HNO3, H2SO4, HBr, HI, HClO4 and HClO3, preferably HCl. The acid can be a weak acid. The weak acid can be acetic acid or HF. The concentration of the acid in the continuous aqueous phase can be between 10 -7 The base may be between 10 and 5 M. The base may be an inorganic base or an organic base, preferably an inorganic base. The inorganic base may be a hydroxide, such as sodium hydroxide and ammonia. For example, the mineral may be about 10 -5 M to 0.01 M NaOH, or about 10 -5 M to about 1 M ammonia. The above listed list of acids and bases and their concentration ranges is not meant to limit the scope of the invention, and other suitable acids and bases that allow for control of the pH of the continuous phase are contemplated herein.

[0296] In the method for preparing capsules according to the present disclosure, pH can be changed throughout the process by adding acid and / or base. For example, the method can be initiated with an aqueous phase at an acidic or neutral pH, and then a base can be added during the process to increase the pH value. Alternatively, the method can be initiated with an aqueous phase at an alkaline or neutral pH, and then an acid can be added during the process to reduce the pH value. In addition, the method can be initiated with an aqueous phase at an acidic or neutral pH, and then an acid can be added during the process to further reduce the pH value. In addition, the method can be initiated with an aqueous phase at an alkaline or neutral pH, and then a base can be added during the process to further increase the pH value. Any suitable pH change can be used. In addition, any suitable combination of acid and base can be used in the method at any time to reach the desired pH. Any of the above-mentioned nanoparticles can be used in the aqueous phase. The nanoparticles can be present in an amount of about 0.01% by weight to about 10% by weight based on the total weight of the aqueous phase.

[0297] The method may include mixing an oil phase and an aqueous phase at a ratio of about 1:10 to about 1:1 oil phase to aqueous phase.

[0298] The second shell member can be formed by blending the capsule having the first shell member with a solution of a second shell member precursor. The solution of the second shell member precursor may include a water-soluble or oil-soluble second shell member precursor. The second shell member precursor may be one or more of the compound of formula (I) as defined above, tetraethoxysilane (TEOS), tetramethoxysilane (TMOS), tetrabutoxysilane (TBOS), triethoxymethylsilane (TEMS), diethoxy-dimethylsilane (DEDMS), trimethylethoxysilane (TMES) and tetraacetoxysilane (TAcS). The second shell member precursor may also include Si(Y) 4-n R n One or more of the type silane monomers, wherein Y is a hydrolyzable group, R is a non-hydrolyzable group, and n can be an integer between 0 and 3. Examples of such monomers are given earlier in this paragraph, and these are not intended to limit the scope of monomers that can be used. The second shell component precursor may include silicates, titanates, aluminates, zirconates and / or zincates. The second shell component precursor may include carbonates and calcium salts. The second shell component precursor may include salts of iron, silver, copper, nickel and / or gold. The second shell component precursor may include zinc, zirconium, silicon, titanium and / or aluminum alkoxides. The second shell component precursor may include silicate solutions such as sodium silicate, tetrasilicon solution, iron sulfate and iron nitrate, titanium alcohol solution, aluminum trialkoxide solution, zinc dialkoxide solution, zirconium alcohol solution, calcium salt solution, carbonate solution One or more. The second shell component containing CaCO3 can be obtained from the combined use of calcium salts and carbonates. The second shell component comprising CaCO 3 may be obtained from a calcium salt by in situ generation of carbonate ions from CO 2 without addition of carbonate.

[0299] The second shell component precursor may comprise any suitable combination of any of the above listed compounds.

[0300] The solution of the second shell component precursor may be added dropwise to the capsule including the first shell component. The solution of the second shell component precursor and the capsule may be mixed together for between 1 minute and 24 hours. The solution of the second shell component precursor and the capsule may be mixed together at room temperature or at an elevated temperature such as 20°C to 100°C.

[0301] The second shell member precursor solution may include the second shell member precursor in an amount between 1 wt % and 50 wt % based on the total weight of the solution of the second shell member precursor.

[0302] The capsule having the first shell component can be mixed with a solution of the second shell component precursor at a pH between 1 and 11. The solution of the second shell precursor can contain an acid and / or a base. The acid can be a strong acid. The strong acid can include one or more of HCl, HNO3, H2SO4, HBr, HI, HClO4, and HClO3, preferably HCl. In other embodiments, the acid can be a weak acid. In embodiments, the weak acid can be acetic acid or HF. The concentration of the acid in the second shell component precursor solution can be between 10 -7 The base may be between 10 and 5 M. The base may be an inorganic base or an organic base, preferably an inorganic base. The inorganic base may be a hydroxide, such as sodium hydroxide and ammonia. For example, the mineral may be about 10 -5 M to 0.01 M NaOH, or about 10 -5 M to about 1 M ammonia. The list of acids and bases enumerated above is not meant to limit the scope of the present invention, and other suitable acids and bases that allow for control of the pH of the second shell component precursor solution are contemplated herein.

[0303] The method of forming the second shell member may include a change in pH during the method. For example, the process of forming the second shell member may be initiated at an acidic or neutral pH, and then a base may be added during the process to increase the pH. Alternatively, the process of forming the second shell member may be initiated at an alkaline or neutral pH, and then an acid may be added during the process to reduce the pH. In addition, the process of forming the second shell member may be initiated at an acidic or neutral pH, and an acid may be added during the process to further reduce the pH. In addition, the process of forming the second shell member may be initiated at an alkaline or neutral pH, and a base may be added during the process to further increase the pH. Any suitable pH change may be used. In addition, any suitable combination of acid and base may be used in the solution of the second shell member precursor at any time to achieve the desired pH. The method of forming the second shell member may include maintaining a stable pH with a maximum deviation of + / -0.5 pH units during the process. For example, the process of forming the second shell member may be maintained at an alkaline, acidic or neutral pH. Alternatively, the process of forming the second shell member may be maintained within a specific pH range by controlling the pH using an acid or a base. Any suitable pH range may be used. Furthermore, any suitable combination of acid and base may be used in the solution of the second shell component precursor at any time to maintain a stable pH within the desired range.

[0304] The emulsion can be cured under conditions that cure the precursor, thereby forming a shell surrounding the core.

[0305] The reaction temperature for curing can be increased to increase the rate at which a cured capsule is obtained. The curing process can cause condensation of the precursor. The curing process can be completed at room temperature or above room temperature. The curing process can be carried out at a temperature of 30°C to 150°C, preferably 50°C to 120°C, more preferably 80°C to 100°C. The curing process can be completed in any suitable period of time so that the capsule shell can be strengthened by the condensation of the precursor material. The curing process can be carried out for 1 minute to 45 days, preferably 1 hour to 7 days, more preferably 1 hour to 24 hours. The capsule is considered to be cured when it no longer collapses. The determination of capsule collapse is described in detail below. During the curing step, it is believed that hydrolysis of the Y portion (from formula (I) and / or (II) occurs, followed by subsequent condensation of the -OH group with another -OH group or another portion of the Y type (wherein the 2 Y portions are not necessarily the same). The hydrolyzed precursor portion will initially condense with the surface portion of the nanoparticle (provided that they contain such a portion). As the shell formation proceeds, the precursor portion will react with the preformed shell.

[0306] The emulsion can be cured so that the shell precursor undergoes condensation. The emulsion can be cured so that the shell precursor reacts with the nanoparticles to undergo condensation. An example of the hydrolysis and condensation steps of the silica-based shell described herein is shown below:

[0307] Hydrolysis: ≡Si-OR+H2O→≡Si-OH+ROH

[0308] Condensation: ≡Si-OH+≡Si-OR→≡Si-O-Si≡+ROH

[0309] ≡Si-OH+≡Si-OH→≡Si-O-Si≡+H2O.

[0310] For example, when using a precursor of formula (I) or (II), the hydrolysis and condensation steps are described below:

[0311] Hydrolysis: ≡M-Y+H2O→≡M-OH+YH

[0312] Condensation: ≡M-OH+≡MY→≡MOM≡+YH

[0313] ≡M-OH+≡M-OH→≡MOM≡+H2O.

[0314] The capsules may be provided as a slurry composition (or simply referred to herein as a "slurry"). The result of the methods described herein may be a slurry containing the capsules. The slurry may be formulated into a product, such as a consumer product.

[0315] Test Method

[0316] Methods for determining logP

[0317] The logarithm of the octanol / water partition coefficient (logP) was calculated for each PRM in the tested fragrance mixture. The logP of the individual PRMs was calculated using the Consensus logP Computational Model, version 14.02 (Linux), purchased from Advanced Chemistry Development Inc. (ACD / Labs) (Toronto, Canada) to provide dimensionless logP values. The Consensus logP Computational Model from ACD / Labs is part of the ACD / Labs model suite.

[0318] Viscosity method

[0319] use The viscosity of the neat product was measured using a DV-E rotational viscometer, spindle 2, at 60 rpm, at about 20°C-21°C.

[0320] Average shell thickness measurement

[0321] The capsule shell, including the first shell component and the second shell component, when present, was measured in nanometers using a focused ion beam scanning electron microscope (FIB-SEM; FEI Helios Nanolab 650) or equivalent on a delivery capsule containing twenty beneficial agents. The sample was prepared by diluting a small amount of liquid capsule dispersion (20 μL) with distilled water (1:10). The suspension was then deposited on an ethanol-cleaned aluminum rod and transferred to a carbon coater (Leica EMACE600 or equivalent). The sample was placed in the coater under vacuum (vacuum level: 10 -5 The sample was dried at 1000 mbar. Next, 25 nm-50 nm of carbon was quickly deposited onto the sample to deposit a conductive carbon layer onto the surface. The aluminum rod was then transferred into a FIB-SEM to prepare a cross section of the capsule. Using the cross-section cleaning mode, cross sections were prepared by ion milling at 30 kV accelerating voltage with an emission current of 2.5 nA. Images were collected in immersion mode (dwell time of about 10 μs) at 5.0 kV and 100 pA with a magnification of about 10,000.

[0322] Images of the broken shells were collected in the form of cross-sectional views of 20 beneficial delivery capsules selected in a random manner without bias due to their size to form a representative sample presenting the distribution of capsule sizes. The shell thickness of each of the 20 capsules was measured at 3 different random locations by drawing a measurement line perpendicular to the tangent line to the outer surface of the capsule shell using the calibrated microscope software. 60 independent thickness measurements were recorded and used to calculate the average thickness.

[0323] Mean and coefficient of variation of volume-weighted capsule diameter

[0324] The capsule size distribution was determined by single particle optical sensing (SPOS), also known as optical particle counting (OPC), using an AccuSizer 780AD instrument or equivalent and the accompanying software CW788 version 1.82 (Particle Sizing Systems, Santa Barbara, California, USA) or equivalent. The instrument was configured with the following conditions and options: flow rate = 1 mL / sec; lower size threshold = 0.50 μm; sensor model = LE400-05SE or equivalent; automatic dilution = on; collection time = 60 seconds; number of channels = 512; container fluid volume = 50 ml; maximum overlap = 9200. The measurement was started by flushing the sensor into a cold state with water until the background count was less than 100. The sample in the suspension of the delivery capsule was introduced and the density of the capsule was adjusted with DI water by automatic dilution as needed to obtain a capsule count of up to 9200 / mL. The suspension was analyzed over a period of 60 seconds. The size range used was 1 μm to 493.3 μm.

[0325] Volume distribution:

[0326]

[0327] in:

[0328] CoV v – Coefficient of variation of volume-weighted size distribution

[0329] σ v – Standard deviation of volume-weighted size distribution

[0330] μ v – Average value of volume-weighted size distribution

[0331] d i – diameter in fraction i

[0332] x i,v – Frequency in fraction i (corresponding to diameter i) of the volume-weighted size distribution

[0333]

[0334] Volumetric core-shell ratio evaluation

[0335] The volume core-shell ratio value is determined as follows, which depends on the average shell thickness as measured by the Shell Thickness Test Method. The volume core-shell ratio of a capsule whose average shell thickness is measured is calculated by the following formula:

[0336]

[0337] where thickness is the average shell thickness of the capsule population measured by FIBSEM, and D 胶囊 is the average volume-weighted diameter of the capsule population measured by optical particle counting.

[0338] This ratio can be converted to a core-shell ratio fraction by calculating the core weight percentage using the following formula:

[0339]

[0340] And the shell percentage can be calculated based on the following formula:

[0341] % shell = 100 - % core.

[0342] Branching method

[0343] The degree of branching of the precursor was determined as follows: The degree of branching was measured using (29Si) nuclear magnetic resonance spectroscopy (NMR).

[0344] Sample preparation

[0345] Each sample was diluted to a 25% solution using deuterated benzene (Benzene-D6 "100%" (D, 99.96%, purchased from Cambridge Isotope Laboratories Inc., Tewksbury, MA, or equivalent). 0.015 M chromium (III) acetylacetonate (99.99% purity, purchased from Sigma-Aldrich, St. Louis, MO, or equivalent) was added as a paramagnetic relaxation reagent. If glass NMR tubes (Wilmed-Lab Glass, Vineland, NJ, or equivalent) were used for analysis, a blank sample must also be prepared by filling the NMR tube with the same type of deuterated solvent used to dissolve the sample. The same glass tube must be used to analyze the blank and the sample.

[0346] Sample analysis

[0347] The degree of branching is determined using a Bruker 400 MHz nuclear magnetic resonance spectroscopy (NMR) instrument or equivalent. Standard silicon (29Si) methods (e.g., from Bruker) are used with default parameters set to a minimum of 1000 scans and a relaxation time of 30 seconds.

[0348] Sample processing

[0349] Use system software such as MestReNova version 12.0.4-22023 (purchased from Mestrelab Research) or equivalent that is applicable to NMR spectrum to store and process samples.Application phase adjustment and background correction.There is a large wide signal extending from-70ppm to-136ppm, which is the result of using glass NMR tubes and the glass present in the probe shell.This signal is suppressed by subtracting the spectrum of blank sample from the spectrum of synthetic sample, and the prerequisite is to analyze blank and sample using the same pipe and the same method parameters.In order to further illustrate any slight differences in data collection, pipes, etc., the region outside the peak of the region of interest should be integrated and normalized to a consistent value.For example, for all blanks and samples, integration-117ppm to-115ppm and integral value is set to 4.

[0350] The resulting spectrum produces up to five major peak areas. The first peak (Q0) corresponds to unreacted TAOS. The second set of peaks (Q1) corresponds to the end groups. The next set of peaks (Q2) corresponds to linear groups. The next set of broad peaks (Q3) are semi-dendritic units. The last set of broad peaks (Q4) are dendritic units. When analyzing PAOS and PBOS, each group falls within a defined ppm range. Representative ranges are described in the following table:

[0351] Group ID The number of bridging oxygen per silicon ppm range Q0 0 -80 to -84 Q1 1 -88 to -91 Q2 2 -93 to -98 Q3 3 -100 to -106 Q4 4 -108 to -115

[0352] Polymethoxysilane has different chemical shifts for Q0 and Q1, overlapping signals for Q2, and unchanged Q3 and Q4, as shown in the following table:

[0353] Group ID The number of bridging oxygen per silicon ppm range Q0 0 -78 to -80 Q1 1 -85 to -88 Q2 2 -91 to -96 Q3 3 -100 to -106 Q4 4 -108 to -115

[0354] The ppm ranges shown in the table above may not apply to all monomers. Other monomers may cause changes in the chemical shift, however, the correct assignment of Q0-Q4 should not be affected.

[0355] Using MestReNova, each set of peaks was integrated and the degree of branching was calculated by the following formula:

[0356]

[0357] Molecular weight and polydispersity index determination method

[0358] The molecular weight (polystyrene equivalent weight average molecular weight (Mw)) and polydispersity index (Mw / Mn) of the condensation layer precursors described herein are determined using size exclusion chromatography with refractive index detection. Mn is the number average molecular weight.

[0359] Sample preparation

[0360] The sample is weighed and then diluted to a target concentration of 10 mg / mL with the solvent used in the instrument system. For example, 50 mg of polyalkoxysilane is weighed into a 5 mL volumetric flask, dissolved and diluted to volume with toluene. After the sample has been dissolved in the solvent, it is passed through a 0.45 um nylon filter and loaded into the instrument autosampler.

[0361] Sample analysis

[0362] An HPLC system with an automatic sampler (e.g., Waters 2695 HPLC separation module, Waters Corporation, Milford MA, or equivalent) connected to a refractive index detector (e.g., Wyatt 2414 refractive index detector, Santa Barbara, CA, or equivalent) is used for polymer analysis. Separation is performed on three chromatographic columns, each 7.8 mm ID × 300 mm long, filled with 5 μm polystyrene-divinylbenzene media, connected in series, having molecular weight cutoffs of 1 kDA, 10 kDA, and 60 kDA, respectively. Suitable chromatographic columns are TSKGel G1000HHR, G2000HHR, and G3000HHR chromatographic columns (purchased from TOSOH Bioscience, King of Prussia, PA) or equivalent. A 6 mm ID × 40 mm long 5 μm polystyrene-divinylbenzene guard column (e.g., TSKgel Guardcolumn HHR-L, TOSOH Bioscience, or equivalent) is used to protect the analytical column. Toluene (HPLC grade or equivalent) was pumped isocratically at 1.0 mL / min while the column and detector were maintained at 25° C. 100 μL of the prepared sample was injected for analysis. Sample data was stored and processed using software with GPC calculation capabilities (e.g., ASTRA version 6.1.7.17 software, available from Wyatt Technologies, Santa Barbara, CA, or equivalent).

[0363] The system is calibrated using ten or more narrow dispersion polystyrene standards (e.g., the standard ReadyCal Set, (e.g., Sigma-Aldrich, PN 76552, or equivalent)) with known molecular weights (in the range of about 0.250 kDa-70 kDa) and using a third order fit of the Mp versus retention time curve.

[0364] Using the system software, calculate and record the weight average molecular weight (Mw) and polydispersity index (Mw / Mn).

[0365] Method for calculating the organic content in the first shell component

[0366] As used herein, the organic moiety in the inorganic shell of the capsule according to the present disclosure is defined as: via hydrolysis of the MX bond connecting the moiety to the inorganic precursor of the metal or semimetal M, and any moiety X that cannot be cleaved from the metal precursor with the metal M (where M belongs to the group of metals and semimetals, and X belongs to the group of nonmetals) under the specific reaction conditions will be considered organic. A minimum degree of hydrolysis of 1% was set as the reaction condition when exposed to neutral pH distilled water for a duration of 24 hours without stirring.

[0367] This method allows one to calculate the theoretical organic content assuming complete conversion of all hydrolyzable groups. Thus, it allows one to assess the theoretical organic percentage for any mixture of silanes, and the result represents only that precursor mixture itself, not the actual organic content in the first shell component. Thus, when a certain percentage of organic content for a first shell component is disclosed anywhere in this document, it should be understood that any mixture containing unhydrolyzed precursors or prepolymerized precursors will have a theoretical organic content according to the following calculation that is lower than the disclosed amount.

[0368] Examples of silanes (but not limited to; see general formula at the end of the document) :

[0369] Consider a mixture of silanes, where the mole fraction of each is Y i , and wherein i is the ID number of each silane. The mixture can be represented as follows:

[0370] Si(XR) 4-n R n

[0371] Wherein XR is a hydrolyzable group under the conditions mentioned in the above definition, R i ni It is not hydrolyzable under the above conditions, and n i =0, 1, 2 or 3.

[0372] This silane mixture will produce a shell with the following general formula:

[0373]

[0374] Then, the weight percent of the organic portion as previously defined can be calculated as follows:

[0375] 1) Find the mole fraction of each precursor (including nanoparticles)

[0376] 2) Determine the general formula of each precursor (including nanoparticles)

[0377] 3) General formula for calculating the mixture of precursor and nanoparticles based on mole fractions

[0378] 4) Converted into reactive silane (all hydrolyzable groups are converted into oxygen groups)

[0379] 5) Calculate the weight ratio of the organic part relative to the total mass (assuming 1 mol of Si in the framework)

[0380] Example :

[0381] raw material formula Mw(g / mol) Weight(g) Amount (mmol) Mole fraction SampleAY <![CDATA[SiO(OEt)2]]> 134 1 7.46 0.57 TEOS <![CDATA[Si(OEt)4]]> 208 0.2 0.96 0.07 DEDMS <![CDATA[Si(OEt)2Me2]]> 148.27 0.2 1.35 0.10 SiO2 NP <![CDATA[SiO2]]> 60 0.2 3.33 0.25

[0382] To calculate the general formula for a mixture, each atomic index in the individual chemical formulas is multiplied by their respective mole fractions. Then, for mixtures, when similar indices occur (usually for ethoxy groups), the sum of the fractional indices is taken.

[0383] Note: Due to the calculation method (the sum of all mole fractions of Si is 1), the sum of all Si fractions in the mixture formula will always add to 1.

[0384] SiO 1*0.57+2*0.25 (OEt) 2*0.57+4*0.07+2*0.10 Me 2*0.10

[0385] SiO 1.07 (OEt) 1.62 Me 0.20

[0386] To convert the unreacted formula to the reacted formula, simply divide the indices of all hydrolyzable groups by 2 and then add them together (along with any pre-existing oxygen groups, if applicable) to obtain the fully reacted silane.

[0387] SiO 1.88 Me 0.20

[0388] In this case, the expected result is SiO 1.9 Me 0.2 , because the sum of all exponents must satisfy the following formula:

[0389] A+B / 2=2,

[0390] Where A is the oxygen atom index and B is the sum of all non-hydrolyzable indices. Small errors may occur during calculation due to rounding and should be corrected. The indices on the oxygen atoms are then readjusted to satisfy the formula.

[0391] Therefore, the final chemical formula is SiO 1.9 Me 0.2 , and the weight ratio of organic matter is calculated as follows:

[0392] Weight ratio = (0.20*15) / (28+1.9*16+0.20*15) = 4.9%

[0393] General :

[0394] The above formula can be generalized by taking into account the valence of the metal or semimetal M, giving the following modified formula:

[0395] M(XR) V-ni R i ni

[0396] And a similar approach is used, but the valence V of the corresponding metal is taken into account.

[0397] Leakage method

[0398] Testing for capsule leakage in liquid compositions (eg, shampoo, conditioner, body wash, and skin care compositions, all of which will hereinafter be referred to as formulations or bases) was performed as follows.

[0399] The homogenized slurry (having a known perfume activity, defined as the weight fraction of perfume in the total slurry) is added and dispersed thoroughly into a known amount of a hair care such as a personal care composition base, such that the perfume weight fraction in the final formulation is 0.25 wt % (or between 0.2 wt % and 0.3 wt %).

[0400] The formulated product was stored in jars or glass containers covered with airtight lids at 35°C and 40% relative humidity for 7 days, and wherein the volume of the head space above the liquid did not exceed 5 times the volume of the liquid itself.

[0401] Sample preparation

[0402] After 7 days of storage, samples of capsules, total oil and free oil were prepared as follows:

[0403] (a) Preparation of capsule samples: Between 0.1 g and 0.11 g of the slurry-containing formulation was introduced into the bottom of a GC sample bottle (see details of the GC sample bottle and method below), and the GC sample bottle was sealed with a crimp cap to create an airtight environment, thereby obtaining a capsule sample.

[0404] This step is performed twice to obtain two readings, and the average of the two values ​​will be used provided they are not too different from each other, in which case the analysis will be repeated. The GC vials are then analyzed by GC / MS as detailed below.

[0405] (b) Preparation of total oil sample: A 1 gram aliquot of the preparation is introduced into a 7 ml cylindrical sample bottle with a diameter of 1 cm to 1.5 cm, which is equipped with a magnetic stirring bar with a length not less than the radius of the 7 ml vial to ensure proper mixing in the sample bottle. The 1 gram aliquot in the 7 ml sample bottle is then mixed on a stirring plate at 500 rpm for 24 hours to ensure that the capsules are broken by the grinding action of the stirring bar on the bottom of the 7 ml sample bottle. An optical microscope can be used to verify that there are no longer intact capsules remaining. In the case of such capsules, this step is repeated for another 24 hours, or until all or nearly all capsules are broken. The preparation containing the broken capsules is then introduced into a GC sample bottle in a similar manner to step (a). This produces a total oil sample. It should be noted that the capsule sample and the total oil sample are not analyzed on the same day because the total oil sample needs to be prepared after the leakage sample has been taken out of storage. It should be noted that the capsule sample and the total oil sample are not analyzed on the same day because the total oil sample needs to be prepared after the capsule sample has been taken out of storage. This does not affect (or substantially does not affect) the results.

[0406] (c) Preparation of free oil sample: A beauty care formulation containing between 0.2 wt % and 0.3 wt % (preferably 0.25 wt %) free oil is prepared by adding and fully dispersing a known amount of a fragrance oil composition into a known amount of a beauty care base. The fragrance oil composition formulated herein is representative of the fragrance oil composition present in the slurry. The free oil formulation is then introduced into a GC sample bottle in a manner similar to step (a). This produces a reference sample that must be used when analyzing capsule samples and total oil samples.

[0407] On each day of analysis, either a capsule sample or a total oil sample must be run along with a reference sample.

[0408] GC / MS Method

[0409] For each test sample and reference sample, an aliquot of 0.1 to 0.11 grams of sample was transferred to a 20 ml headspace vial (Gerstel SPME vial 20 ml, part number 093640-035-00) and immediately sealed (sealed with Gerstel Crimp cap for SPME, part number 093640-050-00). Two headspace vials were prepared for each sample. The sealed headspace vials were then equilibrated. The samples reached equilibrium after 3 hours at room temperature, but could be left standing for longer without compromising or changing the results, until 24 hours after the headspace vials were sealed. After equilibrium, the samples were analyzed by GC / MS.

[0410] GS / MS analysis was performed by sampling the headspace of each vial via SPME (50 / 30 μm DVB / Carboxen / PDMS, Sigma-Aldrich part number 57329-U) with a vial penetration of 25 mm and an extraction time of 1 minute at room temperature. The SPME fiber was then thermally desorbed online into the GC injector (270°C, splitless mode, 0.75 mm SPME inlet liner (Restek, part number 23434) or equivalent, 300 sec desorption time and 43 mm injector penetration). The fragrance composition was analyzed by fast GC / MS in full scan mode. Ion extraction of specific mass was obtained for each component.

[0411] Leakage calculation

[0412] Leakage was calculated for capsule samples and total oil samples separately as follows, where "Area" represents the area under the chromatographic peak corresponding to the PRM of interest:

[0413] For each PRM, the PRM leakage is given by:

[0414]

[0415] Once all PRMs are calculated for both the total oil sample and the capsule sample, the corrected PRM leakage can be calculated using the following formula:

[0416]

[0417] Once the corrected PRM leakage has been calculated for all PRMs, the average leakage can be found by taking the arithmetic mean of each corrected PRM leakage.

[0418] Fragrance composition

[0419] Table 1 Composition of Spice 1

[0420]

[0421] Hair care composition

[0422] Table 2. Hair Care Composition 1

[0423]

[0424] Table 3. Hair Care Composition 2

[0425]

[0426] Unless otherwise stated, the chemicals in the table above were purchased from Sigma Aldrich.

[0427] Table 4. Hair Care Composition 3

[0428]

[0429] Unless otherwise stated, the chemicals in the table above were purchased from Sigma Aldrich. Personal care compositions

[0430] Table 5. Hypothetical Personal Care Composition 1

[0431]

[0432]

[0433] Unless otherwise stated, the chemicals in the table above were purchased from Sigma Aldrich.

[0434] Synthesis of silica shell-based fragrance capsules

[0435] An oil phase was prepared by mixing 2 grams of non-hydrolysable precursor (see below) with 4 grams of perfume 1 and homogenizing.

[0436] The aqueous phase was prepared by adding 5 grams of Aerosil 300 (available from Evonik) to 195 grams of 0.1 M HCl (available from Sigma Aldrich) in a glass container, followed by dispersing the mixture with an IKA S25N-25F Ultraturrax rotor-stator at 15000 rpm during 15 minutes. In case heat was generated during dispersion, the solution was allowed to cool to room temperature before use.

[0437] Once each phase is prepared separately, 16 grams of the above water phase is added to the entire prepared oil phase and the oil phase is dispersed into the water phase using an IKA ultraturrax S25N-10G mixing tool at 13400RPM / 2 minutes to form an oil-in-water emulsion. Once the emulsification step is completed, the resulting emulsion is solidified without stirring using the following temperature profile: 4 hours at 30°C and 16 hours at 90°C, which produces a capsule comprising a first shell component surrounding a fragrance 1 of the present invention.

[0438] To deposit the second shell component, 10 grams of the above capsules were added to 12 grams of demineralized water and the resulting mixture was trimmed with 1 M NaOH until the pH reached 7. Next, 2 ml of a 10 w % demineralized aqueous solution of sodium metasilicate (available from Sigma Aldrich) was added at a rate of 20 microliters / minute using a syringe pump while maintaining the pH between 6.5 and 7.5, while adding 1.6 M HCl (Aq.) and continuously mixing with an overhead mixer at 400 rpm.

[0439] After injection of the second shell component solution had been completed, the capsules were centrifuged at 2500 RPM for 10 minutes and redispersed in deionized water.

[0440] Non-hydrolyzable precursor synthesis

[0441] Under nitrogen atmosphere, 1200g of tetraethoxysilane (TEOS, purchased from Sigma Aldrich) was added to a clean, dry round-bottomed flask equipped with a stirring rod and a distillation apparatus with a Welch fractionation column. 588 grams of acetic anhydride (purchased from Sigma Aldrich) and 7g of tetrakis (trimethylsiloxy) titanium (purchased from Gelest) were added and the contents of the flask were stirred at 135°C for 16 hours. During this period, ethyl acetate generated by the reaction of ethoxysilane groups with acetic anhydride was distilled out. The reaction flask was cooled to room temperature and placed on a rotary evaporator (Buchi Rotovapor R110) used in combination with a water bath and a vacuum pump (Welch 1402DuoSeal) to remove any residual solvent and volatile compounds. The polyethoxysilane (PEOS) generated is a yellow viscous liquid with the following specifications found in Table 6 below. The ratio of TEOS to acetic anhydride can be changed to control the parameters presented in Table 6.

[0442] Specifications of PEOS used to prepare the silica shell capsules of the present invention.

[0443] Table 6

[0444] PEOS parameters result Degree of branching (DB) 0.26 Molecular weight (Mw) 1.63 Polydispersity Index (PDI) 1.81

[0445] Synthesis of non-hydrolyzable PEOS :

[0446] Under nitrogen atmosphere, 1000 grams of TEOS (purchased from Sigma Aldrich) is added in the clean dry round-bottomed flask equipped with stirring rod and distillation equipment.Then, add 564 grams of diacetyl oxide (purchased from Sigma Aldrich) and 5.9 grams of tetrakis (trimethylsiloxide) titanium (purchased from Gelest, Sigma Aldrich), and under agitation the content of flask is heated to 135°C.Under vigorous stirring, temperature of reaction is maintained at 135°C and continues 30 hours, during this period, distill out the organic ester generated by the reaction of alkoxysilane group and diacetyl oxide and the other organic ester generated by the condensation of silyl acetate group and other alkoxysilane groups, and this condensation occurs when generating polyethoxysilane (PEOS).The reaction flask is cooled to room temperature and placed on the rotary evaporator (BuchiRotovapor R110) used in combination with water-bath and vacuum pump (Welch 1402DuoSeal), to remove any residual solvent. The degree of branching (DB), molecular weight (Mw) and polydispersity index (PDI) of the synthesized PEOS polymer are 0.42, 2.99 and 2.70, respectively.

[0447] Capsule synthesis :

[0448] [Five batches were prepared following the following procedure and after the curing step, the 5 batches were combined to produce a combined slurry:

[0449] The oil phase is prepared by mixing 3 g of the PEOS precursor synthesized above with 2 g of a benefit agent and / or core modifier (here a fragrance oil) and homogenizing (or even dissolving if all compounds are miscible). 100 g of an aqueous phase is prepared by mixing 0.5 g of NaCl, 3.5 g of Aerosil 300 fumed silica from Evonik and 96 g of deionized water. The fumed silica is dispersed in the aqueous phase using an IKA ultra-turrax (S25N) at 20,000 rpm for 15 min.

[0450] Once each phase is prepared separately, 5 g of the oil phase is dispersed into 16 g of the aqueous phase using an IKA Ultra-Turrax mixer (S25N-10g) at 25,000 rpm for 5 minutes to achieve the desired average oil droplet diameter. The pH is then adjusted to 1 using 0.1 M HCl added dropwise. Once the emulsification step is complete, the resulting emulsion is left standing at room temperature for 4 hours without stirring, and then at 90° C. for 16 hours until sufficient solidification occurs so that the capsules do not collapse. The five batches are combined after the solidification step to obtain a combined capsule slurry.

[0451] In order to deposit the second shell component, the combined capsule slurry was subjected to post-treatment with a second shell component solution. 50 g of the combined slurry was diluted with 50 g of 0.1 M HCl (aqueous solution). The pH was adjusted to 7 using 1 M NaOH (aqueous solution) added dropwise. The diluted slurry was then treated with a controlled addition (40 μL / min) of a second shell component precursor solution (20 mL of 15 wt % sodium silicate (aqueous solution)) at room temperature using a suspended magnetic stirring reactor at 300 rpm. The pH was kept constant at pH 7 by continuous injection of 1.6 M HCl (aqueous solution) and 1 M NaOH (aqueous) solutions. The capsules were then centrifuged every 10 minutes at 2500 rpm. The supernatant was discarded and the capsules were redispersed in deionized water.

[0452] To test whether the capsules collapse, the slurry was diluted 10 times in deionized water. Several drops of subsequent dilutions were added to a microscope slide and allowed to dry overnight at room temperature. The next day, the dried capsules were observed under an optical microscope through light transmission to assess whether the capsules maintained their spherical shape (without using a cover glass). The capsules remained after drying and did not collapse. The average volume-weighted diameter of the capsules measured was 5.3 μm and the CoV was 46.2%. The percentage of organic content in the shell was 0%.

[0453] Fragrance capsules based on polyacrylate shells

[0454] A population of flavor capsules comprising a polyacrylate shell encapsulating the same flavor composition as the above-described silica shell-based flavor capsules are prepared according to an encapsulant prepared according to the process disclosed in U.S. Publication No. 2011 / 0268802

[0455] Formulated into products

[0456] The capsule slurry synthesized above was combined with the hair care compositions 1 to 3 from Tables X to Y, respectively, in a 50 ml falcon tube (for the amounts used, see the leakage test method above). The capsules were dispersed with a SpeedMixer (Hauschild) at 1200 rpm for 3 minutes and 1100 rpm for 1 minute, after which the capsules and fragrance were thoroughly incorporated into the matrix. Uniform incorporation of the capsules was verified by sampling small aliquots from 3 different locations within the product and observing via optical microscopy that similar amounts of capsules were present in each of the 3 locations.

[0457] This resulted in 6 hair care compositions containing capsules:

[0458] - Hair Care Compositions 1 to 3 + Silica Shell Capsules (Examples of the Invention)

[0459] - Hair Care Compositions 1 to 3 + Polyacrylate Shell Capsules (Comparative Example)

[0460] The above formulated products were then analyzed via the leakage method described in the Test Methods section.

[0461] result

[0462] Leakage results per PRM for silica shell capsules and polyacrylate shell capsules in hair care compositions 1 and 2.

[0463] Table 7

[0464]

[0465] Per PRM leakage results for silica shell capsules and polyacrylate shell capsules in Hair Care Composition 3.

[0466] Table 8

[0467]

[0468] The leakage results in Tables 7 and 8 show two aspects: first, the average leakage of the capsules of the present invention (i.e., silica shell capsules) is the same as or lower than the average leakage of the comparative capsules (polyacrylate shell capsules). Second, in contrast to the comparative capsules (i.e., polyacrylate shell capsules), the leakage of the different PRMs of the fragrance 1 (composition in Table 1) of the capsules of the present invention (i.e., silica shell capsules) are very similar to each other. This shows that the silica shell capsules of the present invention have a very uniform leakage because the standard deviation of the leakage of the different PRMs is very low compared to the comparative capsules. The fact that all PRMs leak at similar rates allows consumers to obtain a more consistent fresh experience, while products in which the PRMs leak at different rates will not have consistent fresh properties throughout the life of the consumer product.

[0469] The dimensions and values ​​disclosed herein should not be understood as being strictly limited to the exact numerical values ​​cited. Instead, unless otherwise indicated, each such dimension is intended to represent the stated value and a functionally equivalent range around that value. For example, a dimension disclosed as "40 mm" is intended to mean "about 40 mm".

[0470] Unless expressly excluded or otherwise limited, each document cited herein, including any cross-referenced or related patent or patent application and any patent application or patent to which this application claims priority or the benefit of, is hereby incorporated by reference in its entirety. The citation of any document is not an admission that it is prior art to any of the present invention disclosed or claimed herein, or an admission that it, by itself or in combination with any one or more of the references, proposes, suggests, or discloses any such invention. In addition, to the extent that any meaning or definition of a term in this invention conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this invention shall govern.

[0471] Although specific embodiments of the present invention have been illustrated and described, it will be apparent to those skilled in the art that various other changes and modifications may be made without departing from the spirit and scope of the present invention. Therefore, it is intended that all such changes and modifications within the scope of the present invention be covered in the appended claims.

Claims

1. A composition comprising: Surfactants; At least one of a fatty alcohol, a cationic polymer, or a mixture thereof; one or more capsules; a capsule comprising a core and a shell surrounding the core; wherein the core comprises a flavor raw material; wherein the shell comprises: a substantially inorganic first shell component comprising a condensation layer and a nanoparticle layer; wherein the condensation layer comprises a condensation product of a precursor; wherein the nanoparticle layer comprises inorganic nanoparticles; and wherein the condensation layer is disposed between the core and the nanoparticle layer; an inorganic second shell member surrounding the first shell member, wherein the second shell member surrounds the nanoparticle layer; wherein the precursor comprises at least one compound of formula (I) or formula (II) or a mixture thereof, Wherein formula (I) is (M v O z Y n ) w , Wherein formula (II) is (M v O z Y n R 1 p ) w , Wherein for formula (I), formula (II) or a mixture thereof: Each M is independently selected from silicon, titanium and aluminum, v is the valence number of M and is 3 or 4, z is 0.5 to 1.6, Each Y is independently selected from -OH, -OR 2 ,halogen, -NH 2 、-NHR 2 、-N(R 2 ) 2 and Where R 2 C 1 To C 20 Alkyl, C 1 To C 20 Alkylene, C 6 To C 22 aryl or 5- to 12-membered heteroaryl, wherein the heteroaryl contains 1 to 3 ring heteroatoms selected from O, N and S, Where R 3 H, C 1 To C 20 Alkyl, C 1 To C 20 Alkylene, C 6 To C 22 aryl or 5- to 12-membered heteroaryl, wherein the heteroaryl contains 1 to 3 ring heteroatoms selected from O, N and S, w is 2 to 2000; Wherein for formula (I), n is 0.7 to (v-1); and Wherein for formula (II), n is 0 to (v-1); Each R 1 Independently selected from: C 1 To C 30 Alkyl; C 1 To C 30 Alkylene; is selected from halogen, -OCF 3 、-NO 2 , -CN, -NC, -OH, -OCN, -NCO, alkoxy, epoxy, amino, mercapto, acryloyl, -CO 2 C(O)-substituted with a member of a -H, -C(O)-alkyl, -C(O)O-aryl, and -C(O)O-heteroaryl group 1 To C 30 Alkyl; and is selected from halogen, -OCF 3 、-NO 2 , -CN, -NC, -OH, -OCN, -NCO, alkoxy, epoxy, amino, mercapto, acryloyl, -C(O)OH, -C(O)O-alkyl, -C(O)O-aryl and -C(O)O-heteroaryl. 1 To C 30 an alkylene group; and p is a number greater than zero and at most pmax, Where pmax = 60 / [9*Mw(R 1 )+8], Where Mw(R 1 ) is R 1 The molecular weight of the group.

2. The composition of claim 1, wherein the composition is at least one of a hair care composition or a personal care composition.

3. The composition according to claim 1 or 2, wherein the precursor comprises at least one compound according to formula (I).

4. The composition according to any one of claims 1 to 3, wherein the precursor comprises at least one compound according to formula (II).

5. A composition according to any one of the preceding claims, wherein the one or more capsules are characterized by one or more of the following: (a) an average volume-weighted capsule diameter of about 10 μm to about 200 μm, preferably about 10 μm to about 190 μm; (b) an average shell thickness of about 170 nm to about 1000 nm; (c) a volume core / shell ratio of about 50:50 to 99:1, preferably 60:40 to 99:1, more preferably 70:30 to 98:2, even more preferably 80:20 to 96:4; (d) the first shell member comprises an organic content of no more than about 5 wt %, preferably no more than about 2 wt %, more preferably about 0 wt % based on the weight of the first shell member; or (e) Mixtures thereof.

6. A composition according to any one of the preceding claims, wherein the compound of formula (I), formula (II), or both, is characterized by one or more of the following: (a) a polystyrene equivalent weight average molecular weight (Mw) of about 700 Da to about 30,000 Da; (b) a degree of branching from 0.2 to about 0.6; (c) a molecular weight polydispersity index of from about 1 to about 20; or (d) mixtures thereof.

7. A composition according to any one of the preceding claims, wherein for formula (I), formula (II) or both, M is silicon, preferably, wherein for formula (I), formula (II) or both, Y is OR, wherein R is selected from a methyl group, an ethyl group, a propyl group or a butyl group, preferably an ethyl group.

8. The composition of any one of the preceding claims, wherein the second shell component comprises a material selected from the group consisting of calcium carbonate, silicon dioxide, and combinations thereof.

9. The composition according to any one of the preceding claims, wherein the inorganic nanoparticles of the first shell component include at least one of metal nanoparticles, mineral nanoparticles, metal oxide nanoparticles or semi-metal oxide nanoparticles, preferably, wherein the inorganic nanoparticles include one or more selected from SiO 2 、TiO 2 、Al 2 O 3 , Fe 2 O 3 , Fe 3 O 4 、CaCO 3 , clay, silver, gold or copper, more preferably, wherein the inorganic nanoparticles include SiO 2 、CaCO 3 、Al 2 O 3 or clay.

10. The composition according to any one of the preceding claims, wherein the inorganic second shell component comprises SiO 2 、TiO 2 、Al 2 O 3 、CaCO 3 , Ca 2 SiO 4 , Fe 2 O 3 , Fe 3 O 4 , iron, silver, nickel, gold, copper or clay, preferably, wherein the inorganic second shell member comprises SiO 2 or CaCO 3 At least one of, more preferably, wherein the inorganic second shell member comprises SiO 2 .

11. The composition of any preceding claim, wherein the composition comprises from about 5% to about 99.5% water, by weight of the composition.

12. A composition according to any one of the preceding claims, wherein the composition is characterized in that -1 and a viscosity of 1 centipoise to 1500 centipoise (1 mPa*s to 1500 mPa*s) at 21°C.

13. A composition according to any one of the preceding claims, wherein the one or more capsules are present at a level of about 0.1% to about 10% by weight of the composition.

14. The composition of claim 2, wherein the hair care composition further comprises a structurant.